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Fourier-Transform Infrared Spectroscopic Imaging of Prostate Histopathology 
 
Daniel Celestino Fernandez 
ABSTRACT 
 
Vibrational spectroscopic imaging techniques have emerged as powerful methods 
of obtaining sensitive spatially resolved molecular information from microscopic 
samples.  The data obtained from such techniques reflect the intrinsic molecular 
chemistry of the sample and in particular yield a wealth of information regarding 
functional groups which comprise the majority of important molecules found in cells and 
tissue.  These spectroscopic imaging techniques also have the advantage of acquisition of 
large numbers of spectral measurements which allow statistical analysis of spectral 
features which are characteristic of the normal histological state as well as different 
pathologic disease states.  Databases of large numbers of samples can be acquired and 
used to build model systems that can be used to predict spatial properties of unknown 
samples.   
The successful construction and application of such a model system relies on the 
ability to compile high-quality spectral database information on a large number of 
samples with minimal sample-to-sample preparation artifact.  Tissue microarrays provide 
a consistent sample preparation for high-throughput infrared spectroscopic profiling of 
histologic specimens.  Tissue arrays consisting of representative normal healthy prostate 
tissue as well as pathologic entities including prostatitis, benign prostatic hypertrophy, 
viii 
and prostatic adenocarcinoma were constructed and used as sample populations for 
infrared spectroscopic imaging at high spatial and spectral resolutions. 
Histological and pathological features of the imaged tissue were correlated with 
consecutive tissue sections stained with standard histologic stains and visualized via 
traditional optical microscopy and reviewed with a trained pathologist.  Spectral analysis 
of histologic class mean spectra and subsequent cross-sample statistical validation were 
used to classify reliable spectral metrics for class discrimination.  Multivariate Gaussian 
maximum likelihood classification algorithms were used to reliably classify all pixels in 
an image scene to one of six different histologic subclasses: epithelium, smooth muscular 
stroma, fibrous stroma, corpora amylacea, lymphocytic infiltration, and blood.  The 
developed database-dependent classification methods were used as a tool to investigate 
subsequent microarrays designed with both normal epithelial tissue as well as 
adenocarcinoma from a large population of patients.  Such investigation led to the 
identification of spectral features that proved useful in the preliminary discrimination of 
benign and malignant prostatic epithelial tissue.  
 
 
1 
Chapter One - Introduction 
Spectroscopy deals with the interaction of various forms of electromagnetic (EM) 
radiation with matter.  Vibrational spectroscopy provides information regarding the 
molecular composition and structure of a wide range of materials including biological 
tissues.  Recent technological advances have led to powerful vibrational imaging 
approaches involving both near and mid-infrared, as well as Raman-based platforms 
providing spatially-resolved chemical information on a microscopic scale[1].  Infrared 
spectroscopic imaging microscopy, in particular, benefits from many decades of 
instrumentation advances and database compilations.  A brief background into the theory 
and techniques of infrared spectroscopy follows. 
1.1 Electromagnetic Spectrum 
The wave nature of electromagnetic (EM) radiation treats the radiation in terms of 
oscillating electric and magnetic fields perpendicular to one another and to the direction 
of wave propagation traveling with the velocity of light.  Certain continuous regions of 
the EM spectrum have been designated and appear in Figure 1.1[2].  Vibrational 
absorption spectra result from the interaction of oscillating dipole moments, which occur 
during molecular vibrations, with the electric field of the radiation, resulting in an energy 
exchange between the radiation and the molecular system. 
Electromagnetic radiation is characterized by its wavelength λ.  The specific units 
typically used to express wavelength vary across the spectrum from angstroms (Å) in the 
gamma ray region to meters in the radio wave region  or ~10-10 to 102 cm, respectively. 
The units of µm are practical for describing radiation in the mid-infrared spectral region.  
In the near-infrared (NIR) region the unit nm typically employed just as it is in the visible 
(VIS) and ultraviolet (UV) spectral regions.  
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Figure 1.1 - The electromagnetic spectrum 
Electromagnetic radiation can also be characterized by its frequency ν, defined as 
the number of oscillations of the magnetic or electric field radiation vector per unit of 
time[2].  The frequency unit is s-1 (oscillations per second), often specified in Hertz (Hz).  
The energy (E) of EM radiation is directly related to its frequency (ν) by the equation 
νhE =  (1.1) 
where h is Plank’s constant with a value h = 6.63 · 10-34 J s.  
The frequency and wavelength (λ) of EM radiation are related by the proportionality 
constant c (the speed of light) according to the equation 
λν
c=  (1.2) 
2 
where c has a value of ~2.99793 · 1010 cm s-1 (in a vacuum).  
Infrared spectroscopists have adopted the convention of expressing frequency in 
terms of wavenumber with the units of cm-1[3].  A simple expression for wavenumber is 
given by 
λν
1=  (1.3) 
The units of wavenumber provide a convenient scale for IR spectroscopy, 
especially the mid-infrared region that spans 200-4000 cm-1.  The units of wavenumber 
are also desirable for IR spectroscopists because they are directly proportional to the 
energy of radiation, which varies inversely with wavelength as described by equation 
1.4[4]. 
λ
hcE =  (1.4) 
The relationships between energy, frequency, and wavelength and the various 
regions of the electromagnetic spectrum are detailed in figure 1.1. The infrared region of 
the electromagnetic spectrum is subdivided into three contiguous regions; the near, mid 
and far infrared regions.  The nomenclature of these prefixes refers to the individual sub-
region’s position relative to the visible region.  Figure 1.2 shows these three regions of 
the infrared spectrum and the ranges they occupy on the wavelength, frequency and 
wavenumber scales. 
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Figure 1.2 - The infrared region of the electromagnetic spectrum 
1.1.1 Interactions of Electromagnetic Radiation with Matter 
All forms of spectroscopy deal with the interaction of radiation and matter.  
Numerous possible types of interactions exist and many involve transitions between 
specific molecular energy states.  The monitoring of the absorption and emission of 
radiation from different regions of electromagnetic spectrum provides information 
regarding these molecular transitions and consequently gives information regarding the 
atomic and molecular composition of samples[5].  
Quantum mechanical treatments describe both the wave and particle nature of 
electromagnetic radiation[5, 6].  As seen in figure 1.1, the electromagnetic spectrum 
spans an extremely wide range of frequencies, and therefore, energies.  There are a 
variety of energy levels that molecules can occupy leading to the possibility of many 
transitions between states.  These energy transitions are of varying magnitudes with 
corresponding frequencies depending upon the specific regions of the spectrum in which 
they occur.  Radiation from different regions of the electromagnetic spectrum are used as 
4 
the basis of the many spectroscopic techniques that exist, for which each technique 
provides molecular information regarding the sample[2].   
Table 1.1 contains examples of different types of spectroscopy based on specific 
regions of the electromagnetic spectrum and the type of chemical information probed. 
rotational tranisitionsmicrowave spectroscopy1mm to 300 mmMicrowave
nuclear spin transitions 
(in magnetic field)
Molecular Structure
NMR Spectroscopy> 300 mmRadio Waves
50 µm to 1mmFar Infrared
IR Absorption spectroscopy
IR Relection spectroscopy
IR emission spectroscopy
2.5 µm to 50 µm Mid Infrared
vibrational transitions
thermal emission
770 nm to 2.5 µmNear Infrared
350 nm to 770 nmVisible (VIS)
electronic transitions
fluorescence emission
vibrational transitions
UV-VIS spectroscopy
fluorescence spectroscopy
Raman spectroscopy
10 nm to 350 nmUltraviolet (UV)
electronic structure
molecular structure
x-ray spectroscopy
x-ray crystallography
0.05 Å to 10 nmX-rays
nuclear decay emissionγ - ray spectroscopy< 0.05 Åγ - rays
informationspectroscopywavelength range (λ)
spectral 
region
 
Table 1.1 -  Spectroscopic techniques utilizing different regions of the electromagnetic spectrum 
1.2 Basis of Infrared Absorption 
Photons in the infrared spectral region have energies representative of transitions 
between molecular vibrational energy levels.   While spectroscopic techniques exist 
which make use of the reflection and emission of infrared radiation, we are most 
concerned with the absorption of infrared radiation.  Nearly all molecules exhibit an 
infrared spectrum, the noted exceptions being homonuclear diatomics, such as the 
common gases N2, O2, and H2[5]. 
5 
Various interactions can occur between radiation and matter that result in the 
transfer of energy.  Quantum mechanical principles require that molecules exist in 
quantized energy states and thus the absorption of energy results in bands that 
characterize an infrared spectrum. 
1.2.1 Requirements for IR Absorption 
The wave nature of quantum mechanics is most simply represented by the time 
independent Schrödinger equation 
ψψ EH =  (1.5) 
where ψ is the wavefunction of the system, H is the Hamiltonian operator, and E is the 
energy of a state characterized by ψ[6].  The wavefunction can be used to calculate the 
transition moment R as shown in the equation 
τ∂= ∫ ψµψ* jiR  (1.6) 
for a transition between states i and j, where µ is the electric dipole moment operator (µ = 
er, e is the electronic charge, r is the distance between the charges), and dτ indicates the 
integration over all space.  For vibrational motions, the electric dipole moment µ is 
expressed as 
...µ)(µ)(µµ
0
2
2
2
2
1
0
0 +⎟⎟⎠
⎞
⎜⎜⎝
⎛
∂
∂−+⎟⎠
⎞⎜⎝
⎛
∂
∂−+=
r
rr
r
rr ee  (1.7) 
where µ0 is the permanent dipole moment, r is the internuclear distance and re is the 
equilibrium bond distance[5].  If we consider only the first two terms in equation 1.7 and 
substitute for µ in equation 1.6 we obtain 
6 
τ∂⎥⎦
⎤⎢⎣
⎡ ⎟⎠
⎞⎜⎝
⎛
∂
∂−+= ∫ ψµ)(µψ
0
0
*
jei r
rrR  (1.8) 
which reduces to 
τ∂⎥⎦
⎤⎢⎣
⎡ ⎟⎠
⎞⎜⎝
⎛
∂
∂−= ∫ ψµ)(ψ
0
*
jei r
rrR  (1.9) 
since µ0 is a constant and  because of the orthogonality of the 
wavefunctions[2]. 
0=τ∂∫ ψψ* ji
From equation 1.8 it is clear that there must be a change in dipole moment during 
the vibration in order for a molecule to absorb infrared radiation.  The selection rules 
predict that the fundamental absorption will occur with vibrational quantum number     
∆υ = ±1 for a harmonic oscillator, with much weaker overtone absorption corresponding 
to ∆υ = ±2 etc. for anharmonic conditions[6].   
All molecules that are more complex than diatomics have multiple vibrational 
modes.  These vibrational modes each have associated energies that correspond to the 
particular frequency or wavenumber of infrared radiation.  The number, type, and 
energies of these vibrations are dictated by the molecular structure of the system in terms 
of the bonds, geometry, atomic masses, and force fields and are thus representative of 
specific molecules[2].  
Vibrational modes that produce a change in dipole moment result in the absorption 
of IR radiation and are termed infrared-active.  Vibrational modes that do not induce in a 
change in dipole moment are termed infrared-inactive. The requirement for a change in 
dipole moment during a molecular vibration explains why, for example, homonuclear 
diatomic molecules do not absorb infrared radiation[4].  
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1.2.2 Number of Vibrational Modes 
While diatomic molecules can vibrate only in one dimension or mode, more 
complicated molecular structures present other possible vibrational modes.  Linear 
molecules with N atoms exhibit 3N-5 vibrational modes, while nonlinear molecules have 
3N-6 vibrational modes[5].  Water (a nonlinear triatomic) and carbon dioxide (a linear 
triatomic) are illustrative examples.  As seen in figure 1.4, the carbon dioxide molecule’s 
additional symmetry provides it with four possible vibrational modes while the water 
molecule has only three.  Note also that the symmetric stretch of the carbon dioxide 
molecule produces no net change in dipole moment and is thus infrared-inactive[4]. 
 
HH
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Vibration
ν3
ν2
ν1
νn
1596 cm-1
3756 cm-1
3652 cm-1
band 
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IR-active
IR-active
IR-active
infrared 
activity
IR-active666 cm
-1
(degenerate)ν2
Bending (in plane)
Bending (out-of-plane)
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Symmetric Stretch
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ν3
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νn
2350 cm-1
1340 cm-1
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IR-inactive
infrared 
activity
O OC
O OC
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O OC
?? ?
A Bwater carbon dioxide
Adapted from [2] 
Figure 1.3 - Vibrational modes and IR activity of water vapor (A) and carbon dioxide (B) molecules 
As molecular structural complexity increases, other types of vibrational modes 
become possible.  The methylene group, for example is capable of six different 
vibrational modes as illustrated in figure 1.4. 
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Figure 1.4 - Vibrational modes of methylene group 
1.2.3 Group Frequencies 
Various chemical functional groups exhibit specific infrared frequencies 
representative of their structures.  Frequencies such as these are known as characteristic 
or group frequencies[4].  Many of the most common functional groups with characteristic 
group frequencies are familiar organic groups.  Functional group frequencies allow the 
spectroscopist to use IR spectra to qualitatively identify structural elements in samples.  
Since vibrational frequency absorption profiles parallel functional group structure, the 
spectroscopist investigating biological material using vibrational techniques often 
depends upon existing databases and extensive compilations of spectral information.  
9 
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1.3 IR Spectral Feature of Tissues 
Modern approaches to histology categorize cells into different types based on their 
primary physiological function[7].  In such a system cells belong to one or more of the 
following groups: epithelial cells, support cells, contractile cells, nerve cells, germ cells, 
blood cells, immune cells, or hormone-secreting cells.   
From a molecular point of view, all of these various types of specialized cells 
encountered in biological tissue are predominately comprised of four major types of 
biomolecules or their subunits: proteins, carbohydrates, lipids, and nucleic acids.   
Additionally, all four of these types of molecules each have a great deal of structural 
redundancy.  That is, they tend to form polymeric molecules based on subunits that while 
different, reflect structural similarity.  For example, thousands of different proteins exist 
in a typical cell, and while the individual structure of each protein is different, they are all 
made from the same set of amino acids, and share a common backbone structure.   
1.3.1 Proteins 
Protein molecules play many fundamental roles in the life of every cell in addition 
to serving various important extracellular functions in many tissues.  The significance of 
proteins to biological organisms cannot be understated and their utility is evident in the 
many functions they perform including: enzymatic catalysis, transport and storage, 
coordinated motion, mechanical support, immune protection, generation and transmission 
of nerve impulses, and control of growth and differentiation[8].  
All proteins are formed as linear chains of amino acid building blocks that can form 
various secondary and tertiary structures.  Eukaryotic proteins are typically assembled 
from a set of 20 different α-amino acids that share a common template and are 
distinguished by unique side chain structures[9].  Figure 1.5 shows the molecular 
structure of a typical amino acid.   
  
Amino 
group
Carboxylate
ion
Side chain is distinctive 
for each amino acid
R
H
+H3N C
O
O-Cα
 
Figure 1.5 - Structure of a typical amino acid 
All amino acids share a common structure that includes a central or α-carbon atom 
bonded to a carboxyl group, an amino group and a hydrogen atom.  At physiologic pH 
the amino group is protonated (NH3+) and the carboxyl group exists as the carboxylate 
ion (COO-)[9], displayed in figure 1.5.  Each different amino acid contains a distinctive 
structure at the side chain position designated as R in figure 1.5.   
The primary protein or polypeptide structure is formed by linking these amino acid 
subunits together in a linear chain via a condensation reaction between the amino and 
carboxyl groups of adjacent amino acids in a linear chain[10].  The linkage that is formed 
between these amino acid subunits is known as a peptide bond and polypeptide chains 
that result form a repeating backbone structure that is the same for all proteins.  Figure 
1.6 shows the basic protein primary structure and the locations of these peptide bonds.  
11 
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Figure 1.6 - Basic polypeptide structure 
The polypeptide backbone structure consists of several functional groups, including 
a C-N group, a C-H group, an NH2 group, and a carbonyl group (C=O).  Since these 
functional groups repeat for every amino acid in a protein regardless of the protein’s 
identity or higher-order structure, the absorbance bands resulting from these structures 
dominate the IR spectra of most proteins.  The most prominent of these absorbances 
include; the Amide I absorption near 1650 cm-1 arising from C=O stretching vibrations 
(80%) weakly coupled to C-N stretching vibrations (20%), the Amide II absorption near 
1545 cm-1 arising from N-H bending vibrations (60%) coupled to C-N stretching 
vibrations (40%), the Amide III absorption near 1236 cm-1 arising from C-N stretching 
vibrations, and the Amide A absorbance near 3290cm-1 arising from N-H stretching 
vibrations[11]. 
In their native states, most proteins do not exist as simple linear polypeptide 
structures, but instead form complex secondary and tertiary structures that impart a 
distinct three-dimensionality to a particular protein.   The most common protein 
secondary structures are the α-helix and β-pleated sheet configurations depicted in figure 
1.7.    
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Figure 1.7 - Common Protein Secondary Structures: α-helix and β–sheet 
β–pleated sheet structures can form between parallel polypeptide chains, or between strands 
with antiparallel orientation, as shown in the figure.  The dotted lines indicate hydrogen 
bonds. 
Both of these recurrent secondary structures involve hydrogen bonding between the 
oxygen atoms of backbone carbonyl groups and the hydrogen atoms of backbone N-H 
groups indicated in the figure as dotted lines.  These structural arrangements change bond 
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angles and other structural parameters, causing frequency shifts of absorbance bands 
arising from backbone vibrations.  As a result, the relationship between IR band positions 
of protein backbone absorbances, most notably the Amide I absorbance near 1650 cm-1, 
and protein structure has been the subject of much work over the past decade[12-16].   
For example, several studies have examined the amide I bands of polypeptides and 
proteins whose structures are known to be dominated by one of the common secondary 
structure motifs, such as α-helix, β–sheet, or unordered structures[17-19].   Such studies 
have led to the development of some empirical rules for the correlation of amide I band 
features and common secondary structural motifs.   
On the basis of these empirical rules, IR bands in the 1660-1650 cm-1 spectral 
region are assigned to α-helices, 1640-1620 cm-1 to β–sheets, 1695-1660 cm-1 to β-sheets 
and β-turns, and 1650-1640 cm-1 to unordered structures[20].  Such empirical rules are 
useful guidelines for obtaining structural information from vibrational spectroscopic 
information, however, many studies show that such rules are not free from 
shortcomings[19].  For instance, IR studies of proteins such as myoglobin and 
hemoglobin, for which x-ray crystallographic data suggests highly helical-structures with 
no β-sheets, have shown Amide I absorbances in the 1640-1620 cm-1 region[21, 22].  
While no conclusive evidence exists to explain the presence of such lower-frequency α-
helix amide I bands, some have suggested that strong hydrogen bonding of peptide 
groups with solvent molecules and distortion of helix structures may contribute to such 
findings[23, 24]. 
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1.3.2 Carbohydrates 
Carbohydrates are aldehyde or ketone compounds with multiple hydroxyl groups.  
These important biomolecules play three central roles in all organisms:  First, they serve 
as energy stores and metabolic intermediates.  Stored glycogen can be readily broken 
down into glucose, a preferred metabolic fuel.  Glucose is broken down to yield 
adenosine triphosphate (ATP), a phosphorylated sugar derivative and universal currency 
of energy in the organism.  The second important role of carbohydrates is as basic 
structural components of nucleic acids.  Ribose and deoxyribose sugars are structural 
units of all nucleotides and ribonucleotides whose sequence in nucleic acids is 
responsible for the storage and expression of genetic information.  A third important role 
of carbohydrates in organisms is that they are often linked to proteins and lipids on cell 
membranes, many playing critical roles in cell signaling and recognition[25, 26]. 
Common cellular carbohydrates have many vibrational spectral features in the 
fingerprint region of the mid-IR spectrum due to various vibrational modes of C-O, C-C, 
and carboxylate groups.  Infrared spectroscopy has been used extensively to help 
characterize biologically important polysaccharide cell-surface components, including 
glycolipids like diacyl sugars[27], cerebrosides[28, 29], gangliosides[30, 31], 
lipopolysaccharides[32-34], and mucopolysaccharides[35].  
1.3.3 Lipids 
Lipids form another important class of biomolecules found in tissue that play many 
important roles.  Like carbohydrates, lipids provide an important source of energy for 
metabolism.  The hydrophobic nature of lipids contributes significantly to their central 
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role in cellular membrane function, providing barriers which partition cells and 
subcellular organelles.  Additionally, lipids perform a variety of other important 
functions, from the coenzyme roles of fat-soluble vitamins to the regulatory roles of 
prostaglandins and steroid hormones to structural and functional roles in the nervous 
system.   
Lipids all share the characteristic of having non-polar, hydrophobic domains.  In 
many cases, long chain fatty acids are responsible for this hydrophobicity, and such lipids 
have many vibrational modes associated with C-H groups across the fingerprint region of 
the mid-IR.  The spectral frequency region between 3000-2800 cm-1 also contains four 
prominent absorbance bands common to many lipids:  the methyl antisymmetric stretch 
(asυCH3) at 2962 cm-1, the methyl symmetric stretch (sυCH3) at 2872 cm-1, the 
antisymmetric CH2 stretch (asυCH2) between 2936-2916 cm-1, and the symmetric CH2 
stretch (sυCH2) between 2863-2843 cm-1[36].   
Unfortunately, most standard methods for the preparation of sectioned tissue 
involve the use of one or more nonpolar solvents such as ethanol or xylenes that remove 
lipids from the tissue section[37, 38].  As a tissue source for FT-IR spectroscopic studies, 
formalin-fixed paraffin-embedded tissue offers some advantages over frozen tissue 
including higher-quality preservation and access to large libraries of preserved tissue, 
however, paraffin exhibits many of these common lipid absorbances, and therefore must 
be removed from tissue sections intended for spectroscopic analysis.  Effective paraffin 
removal requires the use of strong nonpolar solvents such as hexane for several hours at 
temperatures of 40°C further contributing to the extraction of physiologic lipids from 
paraffin-embedded tissue.   
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1.3.4 Nucleic Acids 
Nucleic Acids have been studied extensively in both purified state as well via model 
compounds[39].  The most prominent absorbances reported are due to vibrations of 
several functional groups on the repeating backbone structure of nucleic acids.  These 
include absorbances near 1080cm-1 and 1240 cm-1 attributed respectively to the 
symmetric and asymmetric stretch of phosphodiester (PO2-) moieties[40].  However, the 
ability of IR spectroscopy to attain vibrational information from quiescent nuclear DNA 
from cell preparations or tissue sections has recently been called into question and some 
theoretical analyses of chromatin density and packing used to support the idea that 
nuclear DNA is too dense to produce appreciable absorbances in transmission IR 
spectroscopic experiments[41].   
1.4 FTIR Spectroscopy Background 
Modern instrumental approaches to the collection of spatially-resolved infrared 
spectroscopic data share many characteristics and all benefit from the extensive advances 
made in the field of Fourier transform infrared (FTIR) spectroscopy over the past three 
decades.  Several excellent books[4, 42, 43] have been written on the subject of FT-IR 
spectroscopy and contain comprehensive information on the technology that has been 
implemented for years in commercial FT-IR spectroscopy systems.     
Infrared microspectroscopic imaging systems share many common features.  Most 
consist of a research-grade FT-IR spectrometer that provides an output beam of 
modulated infrared radiation used as a source for an infrared microscope equipped with 
infrared detectors[44].  Modern approaches to the collection of spatially-resolved spectral 
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data are best differentiated in terms of the type of infrared detection employed.  The 
following sections discuss instrumental aspects of spectrometers and infrared 
microscopes, as well as strategies for collecting FT-IR spectroscopic imaging data with 
three different types of infrared detection: single-point mapping, raster scanning with 
linear multichannel detectors, and global FT-IR imaging with Focal Plane Array (FPA) 
detectors.   
1.4.1 FTIR Spectrometers 
The majority of commercial research-grade FTIR spectrometers incorporate a 
broadband infrared source, Michelson interferometer, sample compartment, and infrared 
detection with either deuterated triglycine sulfate (DTGS) or mecury cadmium telluride 
(MCT) single-point detectors.  Many commercial FTIR instruments exist for dedicated 
analyses typically implemented in industrial settings for process assessment and quality 
control analyses.  Such spectrometers are typically designed to be lower in cost than 
research-grade spectrometers, which offer more flexibility in the types of measurements 
that are possible as well as increased sensitivity and higher spectral signal-to-noise ratios 
(SNRs).   
Figure 1.8 shows the schematic design of the Michelson interferometer, which is 
the optical portion of the spectrometer that is used to modulate the radiation.  The 
interferometer is composed of two perpendicular beam paths often referred to as separate 
arms of the interferometer.  These beampaths intersect at the beamsplitter, an optical 
component that when placed at 45-degree angle to the normal both reflects and transmits 
exactly 50% of incident radiation.   In the mid-IR region, beamsplitters are typically 
constructed from potassium bromide (KBr) with a thin coating of germanium (Ge) or 
silicon (Si), and many commercial instruments allow beamsplitters to be changed to other 
materials for coverage of specific spectral regions[42]. 
 
Figure 1.8 - Michelson Interferometer 
As depicted in Figure 1.8, polychromatic radiation from an infrared source, 
typically a ceramic globar, is passed through an aperture to form a beam.  This beam 
strikes the beamsplitter at a 45° angle, dividing the beam in half.  Half of the beam is 
directed at a fixed mirror, while the other half is diverted to a mirror whose displacement 
can be varied along the axis of the incident beam.  After striking these mirrors, the beams 
in the two arms of the interferometer are sent back to the beamsplitter, where they 
recombine and interfere with each other.  The beamsplitter divides the recombined beam 
in half again, sending half back toward the source, while the other half is used for 
spectroscopy and is directed through sample and subsequently detected[4].   
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When the moving mirror occupies a displacement where the pathlengths in the two 
arms of the interferometer are equal, then the recombining beams are precisely in-phase 
and only interfere constructively.   This mirror position produces the most intense beam 
for every frequency of radiation.  As the mirror moves from this position, a pathlength 
difference is created in the two arms of the interferometer that causes specific 
interference patterns for different mirror displacements.    If the mirror is continuously 
scanned, then the intensity of the recombined beam will vary with respect to time in a 
frequency or wavelength dependent manner[2].  
The function of the spectrometer is to encode a modulation on the polychromatic IR 
source radiation such that detection of the intensity of the encoded radiation with respect 
to time or in the “time domain” yields spectral information in the “frequency domain”.   
The “Fourier transform” part of the technique’s name refers to the mathematical 
operation that is required to transform the raw data collected by the instrument in the time 
domain, known as the interferogram, into a intensity profile in the frequency domain, 
otherwise know as an infrared spectrum.    
1.4.2 Infrared Microscopy 
Infrared microspectroscopic imaging systems typically couple the modulated output 
beam of a FTIR spectrometer to an infrared microscope for use as source radiation for 
obtaining spectroscopic information from microscopic regions of a sample.  Infrared 
microscopes perform similarly to conventional optical microscopes and are typically set 
up to image with visible light along the same optical path.  However, they have many 
structural differences that stem from some fundamental properties of infrared radiation. 
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One major limitation of infrared spectroscopy is related to its exceptional molecular 
sensitivity.  As mentioned in section 1.2, all covalently bonded molecules, with the 
exception of homonuclear diatomics, absorb infrared radiation.  Optical components used 
in conventional microscopes are composed almost exclusively of borosilicate glass or 
quartz, both of which have broad absorbances over much of the infrared spectrum.  For 
this reason, infrared microscopes are designed to use reflective optics wherever possible, 
and refractive optics have to be manufactured from alternative materials, such as halide 
salts, which are transparent over the spectral regions of interest[42].   
Most Infrared microscopes use Cassegrain condenser and objective lenses and can 
be operated in either transmission or reflectance modes.  In reflectance mode, one side of 
the Cassegrain objective primary mirror is typically used to direct the radiation onto the 
sample while the opposite portion of the primary mirror is used to collect the reflected 
radiation.  Infrared microscopes are often outfitted with automated high-precision 
motorized mapping stages, which permit the sample to be positioned precisely in the 
plane perpendicular to the optical path.  Most microscopes incorporate a visible light 
source and detection system, typically a video camera.  Adjustable mirrors are used to 
switch between visible and infrared modes and some models incorporate a beamsplitter to 
allow for simultaneous imaging in both spectral regions[45]. 
 The different strategies that can be employed to collect spatially-resolved infrared 
microspectroscopic data depend on the types of infrared detection systems available of 
the microscope[44].  Panels A-C of Figure 1.9 depict three different approaches based 
respectively on single-point, linear-array, and focal plane array (FPA) detection. A 
discussion of each approach follows. 
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Figure 1.9 - Three Instrumental Approaches for collection  of spatially resolved FTIR spectroscopic data 
A) Point-mapping using single element detection; B) Raster-Scan imaging using linear 
multichannel detection; and C) Global FT-IR imaging using 2-D focal plane 
1.4.3 Mapping with Single-Point Detectors 
In single element microspectroscopic instrumentation, spectral information from a 
small, specified area of the sample is obtained by restricting the area illuminated by the 
infrared beam using opaque apertures of controlled size. The collected radiation is then 
diverted to a sensitive detector. To identify the area to be examined, however, a 
corresponding white light optical image is also required.  Clearly, focusing the infrared 
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beam for maximal throughput and minimal dispersion in the sample plane requires the 
optical and infrared paths be parfocal and collinear[45]. 
By restricting the infrared beam to a small spatial area of the sample, and 
sequentially moving to different regularly-spaced sample locations with a high precision 
microscope stage, spatially-resolved spectroscopic data from large sample areas can be 
mapped out point by point. This strategy, often referred to as point-mapping, suffers from 
several limitations.   
 The cross-sectional diameter of the beams used in such infrared microscopes must 
be large enough to fully illuminate the area passed by the largest aperture setting that may 
be employed, for example a 100x100 um square.  There is a tradeoff between the spatial 
resolution of mapping data that can be acquired and corresponding throughput due to the 
need to block out more and more of the available radiation.  Aperture use decreases the 
instrumental throughput due to diffraction when the aperture is of the same dimension as 
the wavelength of light (~3-14um), thus limiting the highest achievable data spatial 
resolution.  Apertures also permit the passage of some diffracted light from outside the 
apertured region.  The use of a second set of apertures in tandem to reject stray radiation 
can improve spatial fidelity, unfortunately at the cost of additional throughput loss.   
Throughput is important because it directly affects the spectral signal to noise ratio 
(SNR), and losses in throughput require larger acquisition times for signal recovery[42].   
Data acquisition time is the major drawback to single-point mapping approaches.  
Spectral information is acquired for each spatial location in the final map one-by-one and 
there is significant time overhead for moving the sample to each new sampling location.  
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1.4.4 Raster-scan Imaging Using Multichannel Detectors  
While single element microspectroscopy provides the capability to obtain spectra 
from small spatial regions, poor SNR characteristics, diffraction effects and stray light 
issues resulting from the use of apertures limit the applicability of this point mapping 
approach.  A multichannel detection approach to circumvent some of these issues has 
recently been implemented[46] with a linear array detector employed to image an area 
corresponding to a rectangular spatial area on the sample.  The sample stage is moved 
precisely to sequentially image a selected spatial area on the sample.  This data collection 
strategy is referred to as push-broom mapping or raster scanning.  The process is 
conceptually similar to point-by-point mapping but takes advantage of the multiple 
channels of detection.  Hence, imaging a large sample area is faster by a factor of n, for a 
linear array detector containing n elements.  The instrument is schematically displayed in 
Figure 1.9B. 
Point mapping detectors are typically 100 – 250 µm in size; in contrast, an 
individual detection element in a linear array detector is of the order of tens of 
micrometers.  Employing a linear array eliminates the need for apertures, as small 
detector elements directly image different sample spatial regions.  For example, a detector 
element 25 µm in size can be operated at 1:1 magnification or 4:1 magnification to 
provide a 25 µm or a 6.25 µm effective pixel size with available, relatively aberration-
free infrared optics.  This approach circumvents the debilitating diffraction effects 
resulting from the use of small apertures in single channel detection systems and provides 
higher quality data when desired spatial resolutions approach the wavelengths of light 
being used.   In addition, the spatial resolution, data quality, and time for data acquisition 
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are no longer coupled as in point mapping methods. The data acquisition time depends 
solely on the size of the image and quality of data desired, and is correlated less with the 
spatial resolution, which is determined by the employed optics.  
A high-precision, motorized stage that reproducibly steps in small increments is 
used and the interferometer is operated in a continuous scan mode.  In combination with 
high performance multichannel detectors, this mode combines high performance 
multichannel detectors with the most desirable properties of rapid-scan interferometry to 
yield high quality spectroscopic imaging data.  
1.4.5 Global FTIR Spectroscopic Imaging 
The state of the art in FTIR microspectroscopic imaging instrumentation is the 
combination of an infrared microscope equipped with a focal plane array (FPA) detector 
and an FTIR spectrometer[47, 48], as shown in Figure 9C.   FPA detectors are 
constructed of thousands of individual detection elements laid out in a two-dimensional 
grid pattern.  An FPA matched to the characteristics of the optical system is capable of 
imaging the entire field of view afforded by the optics and of utilizing a large fraction of 
the infrared radiation spot size at the plane of the sample.  The increase in the number of 
individual detectors with respect to a linear array provides a correspondingly larger 
multichannel advantage.  For example, an FPA with pixel dimensions p x p, provides a p2 
time savings relative to a single element detector and a p2/n time savings compared to a 
linear array detector containing n elements.  For a 128 x 128 element FPA detector 
relative to the single element case, the advantage is a factor of 16,384, while compared to 
a 16-element linear array detector; the multichannel advantage is a factor of 2048.  FPA 
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detectors are also capable of imaging large spatial areas simultaneously without inherent 
inefficiencies of moving the sample or re-setting the interferometer to scan a different 
area.  The considerable reduction in data acquisition times allows for imaging large areas, 
as well as the examination of dynamic processes in a single field of view[49]. 
The first and, to date, most popular approach to FTIR micro-imaging spectrometers 
incorporates a step-scan interferometer[50].  While continuous or rapid-scan 
spectrometry involves scanning the moving mirror at a constant velocity,  a step-scan 
interferometer is capable of stepping the moving mirror to discrete, evenly-spaced 
intervals and maintaining individual mirror positions with very little displacement error.  
A constant retardation over an extended time period allows suitable time for signal 
averaging and for data readout and storage.  Short time delays prior to data acquisition 
are necessary for mirror stabilization at the onset of the step.  Detector signal is integrated 
for only a fraction of the total time required for collection of each frame. The integration 
time, number of frames co-added, and number of interferometer retardation steps (a 
function of desired spectral resolution) determine the total time required for the 
experiment.  Since the integration time determines the data quality, efforts have been 
made to increase the ratio of the integration time to the total data acquisition time[51]. 
Imaging configurations that utilize a rapid scan interferometer have been proposed 
for small arrays[52].  Slow data readout and storage rates for many FPA detectors 
preclude conventional rapid-scan mirror velocities, thus approaches must make use of so 
called slow-scan mirror velocities of ≤ 0.01 cm/s.   A generalized data acquisition scheme 
that permits true rapid scan data acquisition for FPA detectors has been proposed[53], 
where the integration time of individual frames collected by the FPA detector is 
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negligible with respect to the complete interferogram acquisition.  For most FPA 
detectors available today, the motion of the moving mirror does not allow co-addition of 
frames at individual retardations in the continuous scanning mode, but successive single-
frame acquisitions can be averaged to increase data SNRs.  Compared to step-scan data 
acquisition, rapid scan data collection (mirror velocity > 0.025 cm/s) allows for fast 
interferogram capture as no time is spent on mirror stabilization.  The error arising from 
the deviation in mirror position during frame collection is hypothesized to be the next 
largest contributor of noise compared to the dominant contribution from random detector 
noise[50].  At present, the advantages of continuous-scan relative to step-scan approaches 
are a decreased cost of instrumentation and an increased data collection efficiency.  
1.5 Spectroscopic Imaging:  Data Structure and Applications 
Spectroscopic imaging data, regardless of its method of collection, can be 
conceptualized as an image cube with two dimensions corresponding to the spatial axes 
of the sample and the third dimension to the spectral frequency or wavelength.  Digital 
image data is represented as a collection of rectangular picture elements or pixels, each 
with an associated brightness value or magnitude.  Spectroscopic image data can be 
thought of as a collection of super-imposable and spectrally consecutive image planes, 
whose pixel values consist of the spatially independent absorbance at the spectral 
frequency or wavelength specified by the image plane.  Alternatively, the data structure 
can be conceptualized to consist of individual spatial locations or pixels each with an 
associated absorbance spectrum.   The concept of the image cube is represented 
schematically in figure 1.10. 
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Figure 1.10 - Schematic representation of the image cube 
These alternative views of the data structure influence the type of information that 
can be extracted from the data.  For example, we can specify distinct spatial locations in a 
spectroscopic image, and display the associated spectra for simultaneous comparison of 
absorption features across the full spectral region collected.  Alternatively we can specify 
a particular absorption feature of interest and display the associated spectral image plane.  
The brightness values of pixels in such an image will correspond to the sample’s spatial 
distribution of the species responsible for the absorption at the associated spectral 
frequency.     
FTIR imaging of biological systems has demonstrated a potential to complement 
other imaging approaches. For biomedical applications, the technique may be used to 
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examine chemical changes due to pathological abnormalities and to follow histological 
alterations with high accuracy. Non-destructive morphological visualization of chemical 
composition rapidly provides structural and spatial information at an unprecedented level. 
Specifically, thousands of spectra routinely acquired in an imaging experiment may be 
employed for statistically meaningful data analyses, which in the example of biological 
tissue samples may prove ultimately useful in medical diagnoses. Since the visualization 
contrast is dictated by inherent chemical and molecular properties, no sample treatments, 
such as histopathological staining techniques required for optical microscopy, are 
necessary.  
A typical example of the type of tissue information that can be retrieved was 
demonstrated by examining monkey cerebellum sections[54]. Distributions of lipid 
relative to protein allowed easy differentiation of white and gray matter areas.  Purkinje 
cells in rat cerebella, which strongly influence motor coordination and memory 
processes, were visualized using FTIR imaging techniques[55, 56].   Neuropathologic 
effects of a genetic lipid storage disease, Niemann-Pick type C (NPC)[57], were 
distinguishable on the basis of spectral data without the use of external histological 
staining.  Statistical analysis provided a numerical confirmation of these determinations 
consistent with a significant demyelination within the cerebellum of the NPC mouse.  IR 
spectroscopy has been used for a number of years to characterize mineralized structures 
in living organisms (notably, bone). FTIR imaging spectroscopy[58, 59] of bone allows 
spatial variations of a number of chemical components to be non-destructively monitored. 
Correlations in bone between FTIR imaging and optical microscopy involving chemical 
composition, regional morphologies and the developmental processes have been made, 
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and an index of crystallinity/bone maturity could be determined providing structural 
information in a non-destructive manner[60]. 
1.5.1 Image Classification Methods 
One of the most useful approaches to extracting data from such data structures is 
the process of image classification.  Image classification algorithms automatically assign 
each pixel in an image scene to a specific class or group based on its spectral properties 
or pattern.   Unsupervised Classification refers to the automatic partitioning of pixels into 
classes of spectral similarity without the use of any class training data.   Supervised 
Classification is the process of classifying pixels into specific classes based on their 
spectral similarity to user-supplied training data for each class.  
Unsupervised classification methods have the advantage that no extensive prior 
knowledge of the image scene is necessary and the potential for human error is far less 
than with supervised methods.  Additionally, they are useful for finding natural spectral 
patterns and groups in spectral images.  However, they are limited in their usefulness by 
the need to identify the resulting classes after the classification is performed[61].  For this 
reason, such unsupervised methods are of little usefulness for diagnostic implementation. 
Supervised classification methods have several advantages relative to unsupervised 
strategies.  First, the analyst has control over the specific number and identity of class 
categories and can tailor them for specific tasks.  Supervised classification is tied to areas 
of known identity, determined through the process of selecting training regions.  
Additionally, regions of training data can be used during the process of classifier 
development to evaluate classifier performance.   While inaccurate classification of 
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training data indicates serious classification problems and/or problems with training data 
selection, accurate classification of training data does not always assure accurate 
classification of other image data[62].   
Supervised image classification methods have several disadvantages and limitations 
as well.  By creating classes and assigning training populations, the analyst imposes a 
classification structure on the data.  If the user-defined class structure does not match the 
natural class structure within the data, the classes may not be distinct or well defined in 
multidimensional space.  Training populations that do not accurately represent the natural 
distribution of values within a class may result in severe classification error[63].  Finally, 
classes unknown to the analyst and not included in the training data may also be 
misclassified and thereby remain undiscovered.  
1.6 Prostate Background  
1.6.1 Anatomy and Histology  
 In men, the prostate is a retroperitoneal gland located just below the bladder that 
surrounds the urethra.  The gland is divided into four zones: peripheral, central, 
transitional, and periurethral as shown in Figure 3.1.  Distinctions between these zones 
are important because proliferative lesions vary according to the zone in which they 
occur.  For instance, nodular hyperplasia, also known as benign prostatic hypertrophy or 
hyperplasia (BPH), occurs predominantly in the central zone, whereas most 
adenocarcinomas occur in the peripheral zone[64].   
 
adapted from [64] 
Figure 1.11 - Zonal Anatomy of the Prostate 
Histologically, the prostate is a compound tubuloalveolar gland in which glandular 
spaces are lined by epithelium.  Specifically, the gland is lined by a layer of low cuboidal 
epithelium at the basal surface, which is covered by a layer of columnar mucus-secreting 
cells.  The glands contain a discrete basement membrane and are separated by abundant 
fibromuscular stroma.  Some ducts in the gland are lined by tall columnar epithelium, but 
as they approach the urethra, the epithelium changes to more cuboidal and eventually into 
the transitional epithelium that lines the urethra and urinary bladder[65].   
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 While prostatic epithelial tissue and fibromuscular stroma make up the bulk of the 
gland, there are several other important histological features seen in the prostate.  
Numerous blood vessels run throughout the prostate, as well as peripheral nervous tissue 
innervating the gland.  Prostates from older men frequently contain small, spherical 
corpora amylacea comprosed primarily of condensed glycoprotein in the glandular 
lumina[7]. 
1.6.2 Prostate Pathology  
1.6.2.1 Incidence 
 Prostatic carcinoma is the most common form of cancer in men and it is estimated 
that 221,000 new cases will be diagnosed in the United States in 2003[66].  The 
incidence of newly diagnosed cases of prostate cancer in the US was 100,000 in 1988, 
and has risen steadily since then to just under 200,000 in 1994[67].  Mortality in the US 
due to prostate cancer rose from 28,000 to 36,000 during the same time period, however 
recent evidence suggests that mortality has peaked and may be falling[68].  The estimated 
mortality for US men in 2003 is 29,000[66].  This decline has been attributed to increased 
screening efforts and active treatment of localized disease by radiation and radical 
prostatectomy[69].   
1.6.2.2 ‘Latent’ Prostate Cancer 
 In 1954, Franks observed an extraordinarily high prevalence of microscopic foci of 
what he termed ‘latent’ prostate cancer during autopsy of men who died from other 
diseases[70].  His observations have been corroborated by several investigators[71, 72] 
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and the occurrence of these incidental cancers has been shown to increase with age 
affecting approximately 20% of men in their 20’s, 30% of men in their 50’s, and 70% of 
men in their 80’s[73].   The lifetime chance that a man will develop clinically apparent 
prostate cancer is less than 10%[74], thus the majority of these tiny cancers detected at 
autopsy are clinically insignificant.  While it is clear that early diagnosis and treatment of 
prostate adenocarcinoma leads to an improved mortality and morbidity, these findings 
point out the importance of being able to differentiate potentially dangerous cancers from 
the very small, well-differentiated, slow-growing lesions which are unlikely to present 
clinically during the patient’s natural lifespan. 
1.6.2.3 Etiology and Risk Factors 
 It has become clear that genetics play a significant role in the pathogenesis of 
prostate adenocarcinoma.  Male relatives of men who have died from prostate cancer 
have a greater-than-expected incidence of the disease. An early study by Woolf of 228 
men dying of prostate cancer found the relative nearly 3-fold increase in the relative risk 
of first-degree relatives compared to a control group[75].  Subsequent studies have 
confirmed this familial association[76-78], and demonstrated the importance of screening 
PSA values in asymptomatic men from families with 3 or more members affected by 
prostate cancer[74, 79].    
Recent evidence supports the existence of a genuinely hereditary form of early 
onset prostate cancer exhibiting Mendelian autosomal dominant inheritance[80].  The 
exact gene defects have not been elucidated for these families but possible locations have 
been mapped to chromosome 1q24-25[81] as well as the X chromosome suggesting the 
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possibility of X-linked inheritance[82].  Recent evidence suggest that mutations in the 
tumor suppressor genes BRCA-1[83] and BRCA-2[84, 85] confer increased risk of 
developing prostatic adenocarcinoma, and attempts to screen for those at risk are 
currently being studied[86].  The most influential factor conferring risk of developing 
prostate cancer besides familial inheritance is age[87].   African-American men have 
roughly twice the lifetime risk of their white counterparts and higher PSA and tumor 
volume in a study adjusted for age, stage, pathologic stage, Gleason score, and volume of 
benign disease[88]. 
 Other predisposing factors for clinical prostate cancer include the presence of 
testosterone and dihydrotestosterone (DHT), sexual history positive for early first sexual 
experience and multiple sexual partners[89], a diet high in saturated animal fat and low in 
yellow and green vegetables, and environmental or occupational exposure to several 
pollutants including cadmium[90] and the radioactive agents 51Cr, 59Fe, 60Co, and 
65Zn[91].   Vasectomy has been suggested as a possible risk conferring event[92-94] 
though some studies failed to demonstrate a conclusive link[95, 96]. 
1.6.2.4 Diagnosis 
1.6.2.4.1 Clinical Presentation  
With the recent widespread increase of PSA testing in men at risk for prostate 
cancer, a large proportion of patients presenting with the disease are asymptomatic.  
Clinically apparent prostate cancer presents with a spectrum of symptoms related to the 
extent of disease progression.  Urinary symptoms occur in localized as well as advanced 
disease states as well as in extremely common condition of benign prostatic hyperplasia 
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(BPH).  Symptoms related to bladder outflow obstruction, such as hesitancy, poor stream, 
and a sensation of incomplete voiding arise from urethral occlusion by the tumor or 
nodular mass. Urinary frequency and urgency are irritative symptoms that develop due to 
detrusor muscle instability secondary to outflow obstruction or directly by tumor invasion 
of the trigone of the bladder and pelvic nerves.  Invasive cancer can produce other 
symptoms both locally and at distant sites.  Local extension of prostate cancer can present 
with hematuria and/or hemospermia due to invasion of the prostatic urethra or seminal 
vesicles.  Direct invasion of the distal urinary sphincter can cause urinary symptoms 
unrelated to outflow obstruction, while similar invasion of the neurovascular bundles 
posteriorly can lead to erectile dysfunction and pain.  Significant posterior invasion of 
prostate cancer can produce lower bowel symptoms including rectal bleeding and 
constipation due to large intestine obstruction near the rectum.  Symptoms that indicate 
local metastatic disease include bone pain, paraplegia due to cord compression, lymph 
node enlargement, lower limb lymphedema, and loin pain while lethargy, cachexia, and 
hemorrhage may indicate significant systemic metastases[97].   
1.6.2.4.2 Digital Rectal Examination (DRE) 
 Digital rectal examination (DRE) is an inexpensive method of prostate cancer 
detection which has been the focus of many clinical studies[98-103].  One problem with 
the test is that it is subjective and consequently depends on the experience of the 
examiner.  Another is that several other conditions can lead to a false-positive DRE 
finding, including BPH, prostatitis, prostatic calculi, ejaculatory duct anomaly, seminal 
vesicle anomaly, and rectal wall phlebolith or polyp/tumor.  Early stages of prostate 
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cancer (T2a) are characterized by a firm peripheral nodule that does not distort the 
capsule, while more advanced cancers feel hard and more diffuse.  T3 stage tumors often 
present an altered prostate contour while retaining movement of the gland as a whole 
contrasted with the fixed, immobile presentation of T4 stage tumors. 
1.6.2.4.3 Prostate Specific Antigen (PSA) 
 Prostate-specific antigen is a 34 kD glycoprotein specifically found in prostate 
epithelium. It is a neutral serine protease designed to lyse seminal-vesicle protein.  A 
small percentage of PSA normally escapes the prostatic ducts and enters the bloodstream 
where it exists bound mainly to the proteins alpha-1-antichymotrypsin (ACT) and alpha 
macroglobulin (αMG), leaving a small proportion of free PSA in the serum.  Prostate-
specific antigen has established utility for the immunohistochemical identification of 
metastatic disease of prostatic origin, for monitoring of  “biochemical recurrence” after 
therapy and for assessment of disease status in men who are at high risk for biopsy 
complications.      
Screening measures for serum PSA levels have increased the detection rate of early-
stage prostate cancer and are thought to be in part responsible for the downward stage 
migration trend seen in the disease. Considerable variability exists in the world of PSA 
testing.  The cutoff for normal total PSA is accepted to be 4.0 ng/mL though some 
evidence suggests lowering this cutoff in at risk populations.  While most clinical assays 
measure total PSA (bound + free) a significant advantage is afforded when an additional 
test for free PSA is performed. Strong evidence exists that PSA complexed with ACT 
increases in prostatic carcinoma[104, 105] and the lack of availability of a test to 
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specifically measure serum ACT-complexed PSA led to the use of percent free-to-total 
PSA ratio to approximate complexed PSA[106].  Such ratios proved to be especially 
useful in the population of men with total PSA values in the ‘gray zone’ of 2.5 to 10 
ng/ml[107].  Recent development of a reliable assay for ACT-PSA complex[108] looks 
promising and may outperform both total PSA and free-to-total PSA ratio as a more 
specific analyte for cancer[109].  Other methods to improve PSA performance that have 
been studied include PSA density[110, 111], transitional zone density[112], PSA 
velocity[113, 114], and age-specific PSA[115]. 
1.6.2.4.4 Diagnostic Imaging 
 Transrectal ultrasound imaging (TRUS) produces high-resolution images of the 
prostate which are useful for assessing extent of tumor involvement and extension as well 
for guiding needle biopsies to sample areas suspected of harboring tumor foci.  Prostate 
cancers are frequently hypoechoic on TRUS, but can also be isoechoic and more rarely 
hyperechoic[116].  Characteristics of prostate cancer that can be evaluated by TRUS 
include asymmetry of prostate size, shape, indefinite differentiation between the central 
and peripheral zones, and bulging or disruption of the capsule.  Advances in color 
Doppler TRUS allowing analysis of abnormal blood flow look promising for the 
identification of hypervascular regions in the peripheral zone[117].   Computed 
tomography (CT) scanning is useful in metastatic disease to identify the presence of 
lymphadenopathy in the pelvis and is suggested only when other factors identify risk of 
tumor spread (i.e. PSA>20ng/mL and Gleason grade > 7)[118].   Advances in Magnetic 
resonance (MR) imaging endorectal coil design[119] have allowed the acquisition of 
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high-resolution differentially weighted MR images of prostatic disease that are probably 
the most accurate technique currently available for assessing the extent of tumor 
involvement.  Additionally, dynamic contrast enhanced MR imaging may provide tumor 
angiogenesis information[120]. 
1.6.2.5 Biopsy Interpretation and Grading of Prostatic Adenocarcinoma 
 The definitive diagnosis of prostatic adenocarcinoma involves the cytological and 
histological confirmation of the established criteria of malignancy.  The diagnostic 
criteria for carcinomas in biopsies of the prostate involve both architectural and cytologic 
findings[121].   Low to medium power analysis of the arrangement of the glandular acini 
is useful and is the basis of the Gleason scale for grading prostatic adenocarcinoma, the 
predominant scoring system used in the United States[122].  Malignant acini are typically 
scattered haphazardly in the stroma either singly or in clusters. The acini in cancer are 
typically small to medium sized with contours that are less smooth than adjacent normal 
and hyperplastic acini.  Cytologic abnormalities in adenocarcinoma include nuclear and 
nucleolar enlargement present in a majority of malignant cells.  Nucleolar size greater 
than 1.5 mm suggests malignancy while identification of two or more nucleoli in a single 
cell is virtually diagnostic of malignancy[123].   
1.6.2.5.1 Gleason Grading System 
 The Gleason Grading system is the most widely used system for grading prostatic 
adenocarcinoma.  It relies heavily on the examination of low power architectural features 
of the arrangement of prostatic acini.  The Gleason scale rates glandular patterns of 
proliferation on a scale of 1 (most differentiated) to 5 (least differentiated).  Most prostate 
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cancers contain more than one of these patterns and thus the Gleason score for a biopsy 
interpretation is reported as the combination of the two most prominent patterns.  Scores 
range from 2-10 and should be reported as the composite score and its component 
patterns with the most prevalent pattern listed first[124].  For example a biopsy sample 
with a predominant pattern of 3 and a secondary pattern of two would be reported as 
3+2=5.  In practice most cancers have at least one score of 3, and the score of 1 is rarely 
used.   
Gleason grade 1 architecture is described as very well differentiated and is 
minimally distorted.  Neoplastic glands are round, closely packed, single, separate, 
uniform in shape and diameter, and are sharply delineated from fibrovascular stroma. 
Hyperplastic glands also fulfill these criteria, therefore a classification as grade 1 
adenocarcinoma also requires occasional enlarged nucleoli > 1mm in diameter.  In 
practice a Gleason score of 1 is rarely used.  Gleason grade 2 pattern (well differentiated) 
consists of glands which still exhibit a mild but definite stromal separation between 
glands with more variation in the shape and size of glands than is seen in grade 1, but less 
than that of grade 3.  Grade 2 tumors remain circumscribed, and definite separation of the 
malignant glands exists at the tumor periphery suggesting ability to spread to the 
surrounding stroma.  Tumor gland separation is usually less than one average gland 
diameter.  Gleason grade 3 cancers exhibit more extreme variation in size, shape, and 
separation than grade 2 and are typically spaced more than one average gland diameter 
apart. The cytoplasm of grade 3 tumor cells tends to be more basophilic than lower grade 
cancers and nuclei are variable but still larger than lower grades and almost always 
contain prominent nucleoli.  Gleason grade 4 cancers may exhibit any of 4 different 
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morphologic patterns.  Glands with a cribiform pattern have large masses of tumor cells 
punctuated by sieve-like spaces.  Such a pattern was classified as grade 3 by Gleason, 
however, subsequent reclassification to grade 4 was based on the conclusion that most, if 
not all examples of cribiform carcinoma are equivalent to grade 4 carcinoma growing 
within preexisting lumina[125].  The distinctive feature of grade 4 tumors is ragged and 
invading edges in contrast to the smooth edges of grade 3.  Other architectural variants of 
grade 4 adenocarcinoma include solid, microacinar, and papillary.   Gleason grade 5 
tumors completely lack glandular differentiation.  Such tumors can be arranged in solid 
masses, cords, trabeculae, sheets, or may appear as single cells infiltrating the stroma.   
1.6.2.5.2 Importance of Histologic Grading 
 Cancer grade at time of diagnosis has been investigated extensively for correlations 
with other tumor characteristics and clinical behavior.  Every measure of survival and 
recurrence is strongly correlated with cancer grade.  These measures include crude 
survival, tumor-free survival after treatment, metastasis-free survival, and cause-specific 
survival.  Such correlation has been described and validated in numerous studies[126-
129].  Age-adjusted, fifteen-year, cancer-specific mortality rates for men with Gleason 
scores of 2 -4, 5, 6, 7 , and 8-10 are 4-7%, 6-11%, 18-30%, 42-70%, and 60-87% 
respectively[130].  Tumor volume has been correlated with histologic grade in both 
transurethral and radical prostatectomy specimens. A study by McNeal showed that in 
Gleason grade 4 and 5 tumors, 22 of 38 tumors >3.2 cm3 had tumor-positive nodes while 
positive nodes were present in only 1 out of 171 tumors <3.2 cm3.  Two studies 
independently confirmed that the strongest predictor of progression of poorly 
differentiated cancer is tumor volume[129, 131].   
Other studies have found correlations between Gleason grade and PSA levels[132].  
Gleason grade is also one of the strongest and most useful predictors of pathologic stage 
in many studies including the progression of capsular perforation, seminal vesicle 
invasion, and lymph node and bone metastases and can be correlated with expression 
levels of MIB-1 (Ki-57), a tissue marker for proliferation[133-136].  
1.6.2.6 Staging of Prostatic Adenocarcinoma 
 Accurate assessment of the clinical stage of prostatic adenocarcinoma is important 
for the estimation of prognosis, selection of treatment, and evaluation of therapeutic 
results.  The Tumor Node Metastasis (TNM) staging system is used to stage prostatic 
adenocarcinoma.  The current TNM clinical staging is shown below in tables 1.2 and 1.3. 
 TX Primary tumor cannot be assessed 
T0 No evidence of primary tumor 
T1 Clinically inapparent tumor not palpable or visible by imaging 
   T1a Tumor incidental histological finding in 5% or less of tissue resected 
   T1b Tumor incidental histological finding in more than 5% of tissue resected 
   T1c Tumor identified by needle biopsy. Nonpalpable, not visible in imaging. 
T2 Tumor confined within the prostate 
   T2a Tumor involves one lobe 
   T2b Tumor involves both lobes 
T3 Tumor extends through the prostate capsules  
   T3a Unilateral extracapsular extension 
   T3b  Bilateral extracapsular extension 
   T3c Tumor invades the seminal vesicle(s) 
T4 Tumor invades any of bladder neck, external sphincter, or rectum 
   T4a Tumor invades any of bladder neck, external sphincter, or rectum 
   T4b Tumor invades levator muscles and/or the pelvic wall 
adapted from [69] 
Table 1.2 - Staging of primary tumor (T) 
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  NX Regional lymph nodes cannot be assessed 
N0 No regional lymph node metastasis 
N1 Metastasis in regional node(s)  
adapted from [69] 
Table 1.3 - Staging of regional lymph node involvement (N) 
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Chapter Two - Methods 
2.1 Tissue microarrays 
Tissue microarray technology provides a platform for the high throughput analysis 
of tissue speciemens in research[137].  They are used for the target verification of cDNA 
microarray results[138], expression profiling of tumors and tissues[139], as well as 
epidemiology based investigations.  Well-designed tissue arrays reduce the variability of 
experiments performed in a repetitive fashion on large populations, and provide 
consistent sample-to-sample preparation.  
There are currently no reported studies applying vibrational spectroscopic imaging 
techniques to the analysis of tissue microarray specimens.  The tissue microarray is an 
attractive sample platform for pathological spectroscopic imaging approaches for several 
reasons.  First, tissue arrays can be constructed from archival material, allowing for large 
sample populations representative of normal tissue and disease processes to be examined.  
Second, tissue microarrays provide consistent sample preparation across a large sample 
population, minimizing sample-to-sample data variation.  Finally, serial sections of tissue 
microarrays can be analyzed with other techniques to provide complementary 
information invaluable to the interpretation of spectroscopic imaging results. 
2.1.1 Construction of Prostate Tissue Microarrays 
Sections from three prostate tissue microarrays constructed in the Tissue Array 
Research Program Laboratory, Laboratory of Pathology, Center for Cancer Research, of 
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the National Cancer Institute by Dr. Stephen M. Hewitt were used as samples for the 
experiments in this study.  The tissue array donor material was obtained from formalin-
fixed paraffin-embedded blocks from radical prostatectomy specimens taken from cases 
of confirmed prostate adenocarcinoma from specimens obtained from the Cooperative 
Human Tissue Network (CHTN) with approval of the appropriate Institutional Review 
Boards or Office of Human Research Subjects.  The tissue arrays were constructed with a 
0.6 mm needles[139].  The arrays were constructed using a Beecher Instruments (Silver 
Spring, MD) ATA-27 Automated Tissue Arrayer.  
For sake of clarity, the arrays will be referred to by the respective patient 
populations used for their construction.  Specific details regarding the layout of Array P-
16, Array P-40 and Array P-80 appear in the sections below.  
2.1.2 Array P-16 Design 
Array P-16 was constructed using donor tissue from a population of 16 patients 
with confirmed prostate adenocarcinoma.  Eight unmapped 0.6 mm cores from each 
patient were used for a maximum spot number of 128 spots/section.   Donor core 
locations were determined by examination of H&E stained sections of the donor blocks 
and were chosen to provide a representative sampling of both normal prostate histology 
and pathology from each patient.  
2.1.3 Array P-40 Design  
Array P-40 was constructed from donor tissue from a population of 40 patients that 
included the set 16 patients used in the construction of Array P-16.  Five unmapped 0.6 
mm cores from each of the forty patients were used for a maximum spot number of 200 
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spots/section.  Donor core locations were chosen from locations representative of both 
adenocarcinoma and benign epithelium. 
2.1.4 Array P-80 Design 
Array P-80 was constructed of donor tissue from a population of 79 patients with 
confirmed adenocarcinoma.  Two mapped 0.6 mm cores were used from each patient for 
a maximum spot number of 160 spots/section.   H&E-stained sections of the donor tissue 
blocks were used as a guide to carefully select tissue from a region of adenocarcinoma 
for one core and benign epithelium for the corresponding core.  Figure 2.1 below contains 
an image of an H&E stained section of Array P-80 and a corresponding schematic 
representation of the core layout. 
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Figure 2.1 - Array P-80 Layout. 
The right panel contains a visible optical image of an H&E stained section of array P-80.  A 
schematic representation of the core layout appears on the left with patient numbers. 
2.2 Tissue Array Section preparation 
2.2.1 Optical Substrates for Tissue Array Sections 
Standard optical materials, such as those found in microscope slides, are generally 
composed of glass, quartz or fused silica.  These materials all absorb radiation in the 
infrared region at wavelengths longer than 2 µm.  For this reason, transmission 
experiments in the mid-IR require the use of alternative optical materials.  Several 
different halide salts are commonly used as optical materials for IR spectroscopy and 
each possess different optical and physical properties[42].   
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Tissue array sections intended for IR imaging experiments were mounted on 3 mm-
thick, polished, barium fluoride (BaF2) optical windows.  Barium fluoride is transparent 
from 0.15-12.5 µm, which covers the visible and the entire spectral range of the FT-IR 
instrument.  Additionally, BaF2 optical elements have the lowest solubility in water (0. 
17gm/100gm water at 23 °C) of materials with similar optical characteristics[2]. 
2.2.2 Deparaffinization 
Histology grade, low melt (58-62 ºC) paraffin was removed from tissue array 
sections by covering the tissue surface with hexane for 5 minutes.  The samples were 
rinsed with hexane several times and deparaffinization was continued by immersion in 
hexane at 40ºC with continuous stirring for 48 hours.  Every 3-4 hours during the 
deparaffinization process, the immersion vessel was emptied, rinsed thoroughly with 
acetone followed by hexane.   Once dry, the vessel was filled with fresh neat hexane to 
promote flow of embedded paraffin from the tissue.  Thorough deparaffinization was 
assured by monitoring the disappearance of the paraffin band at 1462 cm-1 at several sites 
on the tissue arrays. 
2.2.3 Optical imaging of H&E sections 
Tissue array sections contiguous with those used for IR imaging analysis were 
mounted on glass slides and stained with hematoxylin and eosin for traditional 
histopathological analysis.  H&E stained tissue microarray sections were optically 
imaged using an Olympus BH-2 microscope equipped with a high resolution (3 
megapixel), Peltier cooled, 10-bit, Q-imaging micropublisher digital camera.   Tissue 
array spots were imaged individually through a 4x Olympus ∞-corrected microscope 
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objective and 10x camera eyepiece objective.  The H&E sections were reviewed with a 
pathologist for diagnostic features on a two-headed teaching microscope.  
2.3 Spectroscopic Imaging Instrumentation 
 FT-IR spectroscopic imaging was performed on a Perkin-Elmer (Shelton, CT) 
Spectrum Spotlight 300 imaging microspectrometer equipped with dual mode detection 
system.  The imaging system is comprised of two main optical components: the 
spectrometer and microscope.  The spectrometer houses a ceramic globar broadband 
infrared source, a continuous-scanning Michelson interferometer, and a macro sampling 
area for non-microscopic single point FT-IR measurements.  The modulated infrared 
output beam of the spectrometer is coupled to an infrared microscope and focused onto 
the sample using Cassegrain optics.   
 In transmission mode, the infrared beam is focused onto the sample through a 
Cassegrain condenser.   The condenser position can be varied along the beam axis to 
correct for optical effects caused by substrate thickness and refractive index.  Transmitted 
radiation is collected by a Cassegrain objective and focused onto one of two mercury 
cadmium telluride (MCT) detectors.  Figure 2.1 shows a detailed diagram of the 
microscope and the optical path in transmission mode.  
A traditional single mercury cadmium telluride (MCT) detector is used in the 
instrument’s point mode to take single-point spectroscopic measurements.  Seamless 
software control of variable-width, rotating knife-edge apertures, and a motorized 
mapping stage with a precision error < 1 µm allow flexible collection of high quality 
infrared spectroscopic mapping data in point detection mode.  The microscope portion of 
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the instrument features a visible LED light source and video camera that are linked with 
control software for automated collection of visible-light images as shown in figure 2.1.  
Self-referenced stage position is dynamically linked with both captured visible images 
and spectroscopic imaging results.  This feature allows the operator to choose sample 
areas for spectroscopic imaging experiments via a simple interface by selecting a 
rectangular area on the displayed optical visible image of the sample, and provides 
interactive registration of infrared spectroscopic imaging results with corresponding 
optical visible images. 
 The spotlight 300’s image mode utilizes a 16-element MCT linear array detector to 
build infrared spectroscopic images of any designated rectangular sample area in a line-
mapping fashion.  A fixed optical zoom allows the instrument to collect image data at 
two different spatial resolutions.  The effective pixel size of these two resolution are 25 x 
25 µm in low resolution and 6.25 x 6.25 µm at high resolution.   
 beam from 
spectrometer1
2
3
4
5
6
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Perkin-Elmer Spectrum Spotlight 300 - Microscope Assembly Features
1) Dual-mode Mercury 
Cadmium Telluride (MCT) 
detector.
2) Visible CCD camera for 
optical image acquisition
3) Knife-edge apertures for 
single point 
measurements
4) Dichroic mirrors allow for 
a common infrared and 
visible beam path.
5) Z-fold allows variable 
pixel resolution at the 
sample.
6) High-precision sample 
stage linked directly to 
the interferometer allows 
for synchronized scanning 
and flexible image 
acquisition 
7) LED visible illumination 
source 
 
adapted from [140] 
Figure 2.2 - Spectrum Spotlight 300 Microscope Optical Configuration 
The 1 GB of RAM in the controlling computer limits the size of a single line-
mapping image cube acquisition in the imaging mode.  The maximum sample area size 
that can be collected is thus a function of several collection parameters including spatial 
resolution (high or low), spectral resolution, and spectral wavelength range.  Practical 
considerations such as the liquid nitrogen dewar hold time of 7 hr can also limit the 
maximum size of image data collection in practice. 
2.3.1 Tissue Array FT-IR Data Collection Parameters 
IR Spectroscopic images of the tissue array spots were collected in transmission 
configuration in image mode at the high-resolution zoom setting (pixel size of 6.25µm).  
1641 data points were collected across the spectral region from 4000-720 cm-1 yielding 
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spectra with a resolution of 4 cm-1 (2 cm-1 data point interval).  Four interferograms were 
co-added for each individual measurement to increase data signal-to-noise ratios (SNRs).  
Background spectra consisting of 190 coadded interferograms were collected from 
nearby locations on the BaF2 flats between the tissue spots.   
Data collection with these parameters for a typical 600 µm tissue array spot results 
in a spectroscopic imaging data set with spatial dimensions of ~115 x 115 pixels and a 
file size of approximately 85 MB.  Acquisition time for a typical tissue array spot was 
approximately 35-40 min. The average SNR for a single pixel absorbance spectrum of 
tissue was >500:1.   
2.3.2 Modifications and Environmental Considerations 
The microscope and spectrometer assemblies were enclosed in a Plexiglas housing 
to enable efficient purging with dry nitrogen gas to remove water vapor and to eliminate 
air currents.  The computer controlling the system was situated outside the housing and 
the exhaust streams from the cooling fans of the spectrometer (source) and microscope 
(detector electronics) were vented out of the housing to maintain a stable room 
temperature atmosphere within the housing during data collection.  Once the sample was 
placed on the stage, all positioning, focusing, and experimental control could be 
performed remotely by computer control without opening the housing to the atmosphere.  
After opening the housing for any reason, 20 minutes were allowed for atmospheric 
equilibration before spectroscopic measurements were resumed.  
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2.4 Data Handling and Computational Considerations 
2.4.1 Data Pre-Processing 
In its imaging mode, the Spectrum Spotlight 300 makes use of the dead time while 
the microscope stage is stepped to a new position to perform several computational tasks.  
The functions include interferogram apodization, fast Fourier transform of collected data 
to single beam spectra, and ratioing of sample spectra to background spectra to provide 
absorbance spectra.  Spectroscopic imaging data of tissue array spots were collected 
individually or in small contiguous groups, checked for spectral quality (SNR, baseline 
fluctuations, etc.), and corrected for atmospheric water vapor and carbon dioxide using 
Perkin Elmer proprietary software. 
 The resulting, atmosphere-corrected, spectroscopic images were imported into 
ENVI (RSI inc., Boulder, CO) using software written in IDL by Dr. Rohit Bhargava; all 
subsequent image processing was performed in this software environment.  Some 
downstream statistical analyses and chart plotting were performed using Microsoft Excel 
and Origin. All processing was carried out computers equipped with 1.7 GHz Intel 
Pentium 4 processors and a minimum of 1 GB of RAM.   
Individual tissue array spots were mosaicked into one large spectroscopic image 
dataset for each individual array section for further processing.  For Array P-16, the final 
size of the whole-array spectroscopic image was ~ 500 x 3680 pixels (or ~1.8 million 
individual spectra) producing a file size of ~14 GB.  Spectroscopic image datasets of the 
two sections of Array P-40 were ~ 4370 x 550 pixels or (or ~2.4 million individual 
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spectra) with a file size of ~17 GB.  Array P-80 had a final size of 2160x1250 pixels (or 
~2.7 million spectra) with a file size of ~18.5 GB. 
2.4.2 Spectral Baseline Correction 
Every infrared absorbance spectrum in the image scene was individually baseline 
corrected using custom-designed routines written in IDL by Dr. Rohit Bhargava.  
Regression is used to calculate the values that lie on the line-segment intersecting each 
pair of points.  These values are subsequently subtracted from the spectral absorbance at 
the corresponding frequency, and the process is repeated for each spectrum in the image 
scene.    Several hundred average spectra from different tissue regions on multiple spots 
of Array P-16 were compared and frequency positions observed to be consistent local 
minima were chosen as baseline points.   A list of the frequency positions used as spectral 
baseline points appears in Table 2.1. 
 982
1184
1144
1296
948
1328
1352
1478
1764
1984
2282
2392
2542
2644
2708
3000
3682
3774
spectral 
baseline points
(cm-1)
 
Table 2.1 - Spectral frequencies used for spectroscopic baseline correction 
The baseline-corrected absorbance intensity of the N-H stretching protein backbone 
vibration (or Amide A) at 3290 cm-1 was used to differentiate tissue from empty space on 
the array.   All pixels with an absorbance less than 0.08 at 3290 cm-1 were masked to zero 
for all spectral data points and disregarded during any subsequent processing.    
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Chapter Three - Infrared Spectroscopic Histology of Prostate 
3.1 Visualization of Spectral Images and Verification of Histologic Features 
 Infrared spectroscopic imaging datasets of prostate tissue microarray sections were 
initially visualized by plotting images of the baseline-corrected absorbance at 3290 cm-1.   
This wavenumber position corresponds to the N-H stretching absorbance band or Amide 
A absorbance, a backbone vibration found in all proteins.  Since proteins are basic 
structural elements of all prostate tissue, Amide A absorbance images are useful for 
verifying the presence of spots and structural correlation of features with visible optical 
images of the corresponding H&E stained section. The baseline corrected Amide A 
absorbance images for 4 tissue array spots from a single patient are shown in fig 3.1A 
along with a corresponding H&E stained consecutive section in Fig 3.1B.   
57 
 A B
0.25
0.20
0.15
0.10
0.05
A
B
S
O
R
B
A
N
C
E
 I
N
T
E
N
S
IT
Y
A
B
S
O
R
B
A
N
C
E
 I
N
T
E
N
S
IT
Y
 
Figure 3.1- A) Baseline-corrected N-H stretching (3290cm-1) 
absorbance intensity image of four tissue array spots from a single 
patient on Array P-16  B) Optical images of corresponding H&E 
stained section. 
The tissue microarray sections used for IR spectroscopic imaging experiments are 
subject to harsh deparaffinization conditions of immersion in hexane at 40ºC for 4 hours.  
These conditions caused artifactual damage to a handful of spots in each array sections.  
Typical artifactual problems included partial or complete absence of spots, spots that 
folded over onto themselves, and spots which were partially detached from the surface of 
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the optical flat.  N-H stretching absorbance images such as those seen in figure 3.1A were 
extremely useful for discovering spots that were subject to such damage so that they 
could be eliminated from further analysis. 
3.2 Creation of Ground Truth Data Regions of Interest 
In order to analyze spectra and to train and test classification models, ground truth 
data for different histological features or classes needed to be established.  The name 
ground truth stems from remote sensing applications where field data from various 
sources on the ground are acquired and registered with image data to enable class training 
and/or evaluation of classification performance[61].    
A pathologist examined the matching H&E stained tissue array sections 
microscopically and different histological features present in each spot were marked on 
optical images of the corresponding H&E stained sections.  The region of interest (ROI) 
tool in ENVI allows the user to designate a collection of pixels as belonging to a set, or 
ROI.   ROIs can be manually generated by selecting geometric areas on the spectroscopic 
images with drawing tools such as rectangles, ellipses, or polygons.  Pixels may be added 
to or deleted from ROIs individually, allowing the user to carefully edit such groups.   
ROIs can also be generated from parameters of the data itself, which can be particularly 
useful.  Once created, these ROIs can be used in a variety of image analysis operations 
from image subsetting and masking to statistical analyses and image classification.   
In analyzing the spectroscopic datasets, specific images derived from various  
absorbance band ratios provided high contrast for discerning different histologic features 
in the tissue.  Fig 3.2A shows the 1080 cm-1/1544 cm-1 absorbance band ratio image of 
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four tissue array spots from a single patient on Array P16.   The 1080 cm-1 band is 
attributed to a C-O stretching vibration of glycogen and the band at 1544 cm-1 to the 
Amide II vibration of the protein backbone.  The 1080 cm-1/1544 cm-1 image provides 
high contrast between prostate epithelium and stroma.  Areas of higher ratio intensity in 
Fig 3.2A correspond to the basophilic-staining epithelial regions in the optical image of 
the corresponding H&E stained section in panel B.  The eosinophilic stromal regions of 
the tissue correspond to lower intensity regions of the 1080 cm-1/1544 cm-1 ratio image 
suggesting that glycogen/protein levels are higher in epithelial tissue than in stroma.   
Another absorbance band ratio that produced useful images was 1206 cm-1/1544 
cm-1.   At the spectral resolution used of 4 cm-1, the absorbance feature at 1206 cm-1 
typically appears as a shoulder off the higher intensity combination band at 1236 cm-1 
attributed to both Amide III vibrational mode of proteins and the asymmetric stretch of 
phosphodiester (PO2-) groups in phospholipids and nucleic acids.   Fig 3.2C shows the 
1206 cm-1/1544 cm-1 absorbance band ratio image of 4 tissue array spots taken from a 
different patient on Array P-16.  Comparison with the image of the matching H&E 
stained section (Fig 3.2D) reveals poor contrast between epithelial and stromal tissues, 
however, excellent contrast is seen between an area of lymphocytic infiltration, indicated 
by the highest intensity area in the upper spot, and the surrounding stromal and epithelial 
components.  
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Figure 3.2 - Absorbance Band Ratio Images of tissue array spots from Array P-16 
Various absorbance band images and band ratio images were interactively overlaid 
and used to assist the ROI creation process.  Using the pathologist-reviewed, marked 
optical images of the H&E stained sections as a guide, collections of pixels in the 
spectroscopic image of each tissue spot were assigned to one of the ten histological class 
ROIs listed in table 3.1.  The epithelial class includes pixels from different 
histopathological states, including normal benign epithelium, benign prostatic hyperplasia 
(BPH), prostatic intraepithelial neoplasia (PIN), and prostatic adenocarcinoma (CaP).  
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Stromal histological features were separated into 3 subclasses: fibrous stroma, smooth 
muscular stroma, and mixed stroma based on the H&E section images and spectral 
differences noted between these three subclasses.  Remaining classes included sites of 
lymphocytic infiltration, vessel endothelium and muscular coat, peripheral nerve tissue, 
ganglion cells, blood cells, and corpora amylacea.  In making the component analysis, 
much care was taken to include only those pixels that were definitively representative of 
a particular class, and therefore pixels near edges or class borders were eliminated to 
insure that class spectral statistics remain uncontaminated.   
 number of spectra in class ROI
162956
1039
628
438
2362
359
1976
2751
74609
11444
80293
16 patient array
1134lymphocytes
153554Total
828corpora amylacea
767blood cells
0ganglion cells
0peripheral nerve
54endothelium
560smooth muscle stroma
30144mixed stroma
19092fibrous stroma
1134epithelial tissue
40 patient array
Histologic Class
 
Table 3.1 - Histologic class population data 
Class data were stored separately for each spot and histologic class as individual 
regions of interest (ROI) in ENVI and could be operated on individually at the spot level 
or merged to patient level or into a single ROI at the class level.  This flexibility enables 
downstream comparisons to be made at the spot-spot and patient-patient level for each 
class and across classes. 
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3.3 Spectral analysis of histologic features and metric selection 
 The individual ROIs from each spot were merged together to form a single large 
ROI for each of the ten histologic classes for each array.  The total number of pixels, 
where each pixel represents an individual spectrum, is shown for each histologic class in 
table 3.1.  The spectra from each ROI were averaged to create a mean spectrum for each 
class, displayed in figure 3.3. 
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Figure 3.3 - Histologic class mean spectra 
The spectra were calculated from baseline corrected spectra and were normalized to amide II 
absorbance at 1544cm-1.  Panel A contains the full spectral window collected 720-4000 cm -1.  Panels 
B, C, and D contain enlargements of the corresponding boxes in panel A. 
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3.4 Construction of a Supervised Classification Model for Prostate Histology 
3.4.1 Spectral Data Reduction 
The mean spectra for each histologic class were compared and spectral features, 
frequencies, and band ratios could be identified for distinguishing the various classes 
from one another.  A set of metrics was developed involving absorbance band ratios and 
peak centers of gravity for features across the entire spectral region.  Metric values were 
computed using software routines written in the statistical language IDL by Dr. Rohit 
Bhargava and implemented in the remote sensing software environment ENVI (RSI, inc., 
Boulder, CO).   
 Histograms of each training class population were plotted and compared for each 
metric.   Most distributions approximated a normal distribution and showed some 
variation in mean and standard deviation between classes.  Metrics which did not 
approximate a normal distribution for most classes were discarded, since such data can 
lead to poor performance with parametric classification methods, particularly with 
Gaussian Maximum Likelihood classification algorithms[62] discussed below in section 
3.4.2 .   Metrics that showed no significant variation between classes were also discarded, 
since their inclusion would likely add only noise to the classification.  The spectroscopic 
imaging dataset was reduced from 1641 spectral bands (wavenumber positions) to a 20-
band set of candidate spectral metrics, reducing the tissue array imaging dataset from 14 
GB to a manageable 160 MB. 
The construction of successful classification model is by nature an interactive, 
process.  Information is gained in small bits as individual problems are identified and 
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strategies are altered to adjust.  A common problem encountered is the existence of 
classes which possess bimodal distributions in several spectral bands.  Such observations 
typically indicate that the class is composed of two or more spectrally distinct subclasses.  
In such cases, classification accuracy can often be dramatically improved by splitting the 
training data for the suspect class into separate classes[63].  Similar histogram analysis 
performed on several absorbance band ratio images from early FT-IR imaging studies of 
non-array prostate tissue indicated that stromal tissue in the prostate was composed of 
spectrally distinct subclasses.  These preliminary results formed the basis for splitting 
stroma into three separate subclasses: fibrous stroma, smooth muscular stroma, and 
mixed fibromuscular stroma.   
A listing of the parameters for each of the 20 candidate spectral metrics appears 
below in Table 3.2. 
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Table 3.2 - Histology Spectral Metric Definitions 
3.4.2 Image  Classification 
Several different algorithms exist for the supervised classification of multispectral 
image data.  Some of the more simplistic classification algorithms such as parallelpiped 
or minimum-distance approaches do not consider variation that may be present within 
spectral classes and do not perform well when frequency distributions from separate 
classes overlap[62].   
Histogram analysis of individual metric value class distributions indicated that both 
significant intraclass variation in spectral metric values exist and that significant overlap 
between metric value frequency distributions of different classes was common.  As 
examples, individual class histograms for the three most common or populated training 
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classes (epithelium, mixed stroma, and fibrous stroma) are displayed for metric 02 values 
(Fig. 3.4A) and for metric 11 values (Fig 3.4B). 
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Figure 3.4- Histograms of metric value class frequency distribution for the three 
most populated classes (epithelium, mixed stroma, & fibrous stroma) for:  A) Metric 
02 (band ratio 1080/1544cm-1), and B) Metric 11 (band ratio 1400/1390 cm-1) 
A parametric approach to supervised classification that is particularly well suited to 
deal with such natural intraclass spectral variation and interclass overlap of metric 
frequency distributions is the Gaussian Maximum Likelihood (GML) Classifier[62].  An 
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n-dimensional probability surface for each class is generated from both class mean and 
variance statistics for training data consisting of n spectral bands.  As classification 
ensues, each pixel’s discrete spectrum can be used to calculate the corresponding 
conditional probability or likelihood that the pixel belongs to each class separately from 
the individual class n-dimensional probability surfaces[63].  The pixel is then assigned to 
the class with the highest conditional probability.  Classification sensitivity can be 
adjusted by imposing minimum probability thresholds that cause pixels below a user-
supplied minimum conditional probability to be relabeled as unclassified. 
A supervised Gaussian Maximum Likelihood (GML) algorithm implemented in 
ENVI was used to classify the 20 metric dataset of the entire tissue array.  The 10 
different histologic class ROIs were used as input to train the classifier.  No thresholding 
was imposed during the classification forcing each pixel in the tissue array image scene 
to be classified as one of the ten histologic subtypes.  The 10 histologic training ROIs 
were used next as a preliminary validation set to evaluate the performance of the 
classification.   
3.4.3 Array P-16, 20-metric, GML Self-classification results 
An extremely useful tool for the evaluation of image classification results is the 
expression of classification accuracy in terms of an error matrix.  Such error matrices are 
also commonly referred to (appropriately) as confusion matrices.  Error matrices 
compare, on a class-by-class basis, the relationship between known reference data 
(ground truth class data) and the corresponding results of a classification attempt.   
 The same 10 histology class ROIs from Array P-16 that were used as training input 
for the 20-metric, Gaussian Maximum Likelihood (GML) classification of all tissue on 
Array P-16 were used as ground truth to calculate an error matrix for the same 
classification.  These data appear below as Table 3.3. 
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Table 3.3 - Error Matrix of supervised GML Classification results using 20 spectroscopic metrics 
The classifier was implemented in ENVI and was trained on sets of reference spectra assigned to one 
of ten histologic classes.  All matrix values are given in units of percent of ground truth class pixels. 
The columns represent the ground truth or correct class designation and the rows 
represent the result class as assigned by the GML classifier.  The numbers at each 
position are the percent of the number of total pixels in the column (ground truth class) 
that were classified as the class of the row.  For example, if we examine the epithelium 
column, we see that 89.64% of epithelial pixels were correctly classified, 0.25 % of 
epithelial pixels were misclassified as fibrous stroma, 3.48% of epithelial pixels were 
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misclassified as lymphocytes, etc. The values that occupy the diagonal of the confusion 
matrix (shown in red in Table 3.3) are the classification accuracy for a given class.  These 
values show that this initial classification attempt performs above 94% for all classes 
except for epithelium (89.6%), mixed stroma (70.4%), and blood (87.7%). 
3.4.4 Leave-one-out metric evaluation 
It was clear from the histogram analysis of the individual metrics in the original set 
of 20 that certain metrics were better for discriminating certain classes than others.  In 
light of the significant frequency distribution overlaps seen in many cases, a given 
metric’s inclusion in the classification attempt might provide little to modest increase in 
classification accuracy for single class or small number of classes while causing a 
significant decrease in accuracy in the remaining classes.  To test for the presence of such 
contaminating metrics in the original set of 20, a leave-one-out analysis was performed.  
The image scene was reclassified 20 separate times using a total of 19 spectral metrics 
per attempt, leaving out a different metric for each successive trial.  The accuracy change 
for the 3 classes with the worst 20-metric classification accuracy (epithelium, mixed 
stroma, and blood) with respect to the 20 metric classification was recorded for each 
successive trial and is shown below in Figure 3.5.  
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Figure 3.5 - Graphical Representation of results of the leave-one-out analysis 
The tissue array data was reclassified 20 separate times with a total of 19 metrics, sequentially 
leaving out a different metric.  The percent change in classification accuracy for the three 
histologic classes which performed poorly in the 20 metric classification attempt (epithelium, 
mixed stroma, and blood) are plotted with the metric number left out varying along the x-axis. 
 While the results of the leave one out analysis were analyzed for every class, for 
the sake of clarity, Figure 3.5 contains only data from the three classes (epithelium, 
mixed stroma, and blood) which had the most classification error in the original 20-
metric classification.  These three classes stand to benefit most from the removal of a 
possible contaminating metric, and from the results in Fig 3.5 we see that two metrics 
clearly stood out as detrimental to classification accuracy.  All three of the poorly 
classified classes (epithelium, mixed stroma, and blood) show a significant increase in 
accuracy when metric 9 and metric 18 are left out individually.   
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3.4.5 Array P-16, 18-metric GML Classification Results 
  Reclassification with the GML algorithm in the absence of both metric 9 and 
metric 18 produced the most promising self-evaluated results, which are represented as a 
error matrix in Table 3.4.  The training ROIs were used as ground truth input to generate 
the error matrix results.  
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Table 3.4 - Confusion matrix of supervised GML Classification attempt using 18 spectroscopic metrics 
Metric 9 and metric 18 were left out of the original set of 20.   
All 10 classes are classified at an accuracy above 92.5%.  A color-coded classified 
result image of four tissue array spots from a single patient are shown in figure 3.6 with 
the corresponding H&E section in panel B for comparison.  Classification 
correspondence with the histological features observed in the  H&E section is 
outstanding.   
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Figure 3.6 - Classification results for 2 tissue array spots from the same patient 
GML Classification was performed with a total of 18 metrics selected from the results of the leave-one-out 
analysis as shown in figure 3.5. 
 Epithelial pixels were classified correctly 95.6% of the time with the majority of 
misclassification as ganglion (2.8%) and lymphocytes (0.9%).  Mixed stroma pixels were 
classified correctly 92.5% of the time with the majority of misclassification , not 
surprisingly, as smooth muscle stroma (5.5%) and fibrous stroma (1.15%).   
Fibrous stroma pixels were classified correctly 93% of the time with the major 
misclassification predominately occurring as nerve (4%).  Interestingly, nerve pixels were 
correctly classified with an accuracy of 93.7% with the majority of misclassification as 
fibrous stroma (3.7%).   Upon close inspection, the mean spectra of the fibrous stroma 
and nerve training ROI’s proved to have many similarities, as seen in figure 3.3.  Spectral 
similarities between nerve and fibrous stroma include absorbance peaks at 1034 cm-1 and 
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1206 cm-1, and a shoulder at 1280cm-1.  As a result of this spectral similarity, a 
substantial number of pixels at the stromal-epithelial interface were observed to be  
misclassified as nerve when they probably belong to the fibrous stroma or mixed stroma 
class. 
Smooth muscle stroma pixels were classified with an accuracy of 94% with the 
majority of misclassification as mixed stroma (2.8%) and endothelium (2%).  Again of 
note is that while endothelium was correctly classified 92.8% of the time, the majority of 
misclassification occurred as smooth muscle stroma.   While fibrous stroma and nerve 
represent a pair of classes whose similarity seems likely based on a compositional 
similarity, the connection between endothelium and smooth muscle stroma is probably 
due to impurity in the endothelial training class.  The endothelial training class by far had 
the fewest number of training spectra at 359.  This reflects both the paucity of discernible 
endothelial tissue visible in prostate sections on H&E staining and the difficulty in 
correctly identifying it in corresponding IR spectroscopic images.  Endothelial cells are 
typically very hard to identify as they are single-layered, and are contiguous with the 
smooth muscular media which is more pronounced in arterial vessels.[7]  With a single 
pixel in the IR spectroscopic images representing 6.25 µm of tissue per edge, it seems 
highly likely some of the endothelial training pixels are contaminated with signal from 
smooth muscle tissue of the vessel media.  Similarly, blood pixels were classified with an 
accuracy of 97.6% with the majority of misclassification as endothelium.   
Lymphocyte pixels were classified with an accuracy of 96.2% with all of the 
misclassification as epithelial pixels (3.8%).  A large proportion of pixels which were 
incorrectly classified as lyphocytes probably represent true spectral mixtures of different 
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class types, since lymphocytic infiltration necessarily overlays regions of stroma and 
epithelial tissue.  Ganglion pixels were classified to an impressive 97.3% with the 
majority of misclassification as nerve.  Corpora amylacea were classified to an accuracy 
of 99.8%.  While this accuracy value seems aberrantly high compared with the other 
classes, examination of the class mean spectrum of corpora amylacea compared with the 
other class mean spectra (figure 3.3) reveals that it is quite extreme compared with every 
other spectrum which probably accounts for the high self-classification accuracy. 
3.5 Validation of Prostate Histology Classification Model 
 These impressive results with a simple set of 20 metrics hint at the promise of this 
approach.  One can be certain that many more metrics exist that if included would 
improve classification accuracy.  One of the many advantages of this approach is that we 
can design our metrics to highlight the property of a spectral feature that is changing 
across classes, whether it be band height relative to another band or band center of 
gravity irrespective of height.  Metrics which measure other spectral properties such as 
absorbance band widths are other obvious choices to be tested in the future, while data 
collection at higher spectral resolution and with higher single-pixel SNRs will uncover 
newly resolvable spectral features which can be harnessed as metrics to improve 
classification accuracy. 
 An important caveat mentioned prominently most remote sensing references [61-
63, 141] is that accuracy estimates made using training data regions as ground truth do 
not necessarily indicate that similar results will be seen when classifying other regions of 
the image scene.  The pixels in the ROI sets used for classifier training and evaluation 
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make up only a tiny fraction of the total number of tissue pixels in the full spectroscopic 
image of Array P-16.  Several spots from Array P-16 were purposely avoided during the 
training ROI selection process so that they could be used for qualitative validation of 
promising classification results.  Examination of these spots with respect to their 
matching H&E stained sections gave a qualitative sense that the 18-metric classification 
was performing quite well on tissue that was not included in the training sets.  As an 
example, the lower spot in Figure 3.6 contains no pixels used in any of the 10 training 
ROIs, any the classification results agree well with the image of the matching H&E-
stained section.   
3.5.1 Cross-Array Validation  
As noted in table 3.2, a set of histology ground truth ROIs was constructed for the 
spectroscopic imaging dataset of Array P-40 in the same manner as described in section 
3.2 in reference to Array P-16.   
 In light of the observed classification trends seen in the 18 metric, P-16 training 
data error matrix in Table 3.3 and discussed in section 3.5, adjustments were made to the 
classification model class structure.  The endothelial class was discarded due to 
insufficient ground truth ROI pixel populations on both Array P-16 and Array P-40.  The 
extremely thin nature of this tissue structure on cross-section further adds to the difficulty 
in both establishing ground truth information for this potential class and evaluating 
results since pixels in the spectroscopic images have a size of  6.25 µm of tissue per pixel 
edge.  Visual analysis of the H&E-stained section of Array P-40 revealed almost no 
contiguous areas of pure smooth muscle as seen frequently in Array P-16.  Furthermore, 
the 18-Metric self-classification results indicated that most of the misclassified mixed 
stroma pixels were incorrectly classified as smooth muscle stroma and vice versa.   
Consequently, the ground truth data smooth muscle stroma class and mixed stroma 
classes were merged into a single mixed stroma class separately for both Array P-16 and 
Array P-40.  The spectral similarity and commission errors seen between the fibrous 
stroma and nerve classes suggested they might also be better off combined as a single 
fibrous-stroma class.  However, no appreciable nerve or ganglion tissue was found in any 
of the Array P-40 spots so both the P-16 nerve and ganglion training data were excluded 
from the cross-array classification attempt.  These adjustments to the histology class 
structure result in a total of 6 classes.  Table 3.5 contains the revised, 6-class, histology 
ground truth class ROI set population data for both Array P-16 and Array P-40. 
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Table 3.5 - Revised 6-class histology ground truth ROIs for Array P-16 and Array P-40 
The 6 ground truth ROIs for Array P-16 listed in Table 3.5 were used as training 
data for supervised classification of all tissue from Array P-40.  The same 18 metrics 
used for classification of Array P-16 in section 3.5.5 were used for both the training data 
from Array P-16 and for P-40 image data to be classified by the GML algorithm.  
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 All pixels in the P-40 image scene were classified and the 6 ground truth class ROIs 
from Array P-40 were used to construct an error matrix for the cross-array classification 
result which appears below in Table 3.6. 
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Table 3.6 - Error Matrix for 6-Class, GML Classification Results 
The classifier was trained on 6-class ground truth data from Array P-16 and applied to classify all 
tissue pixels in the image data from Array P-40.  The same set of 18 spectral metrics used in section 
3.5.5 were used for this classification.  
The error matrix results indicate that classification accuracy in 5 out of 6 classes 
exceeds 94.5%.  Fibrous stroma was the class with the lowest classification accuracy at 
91.5%, however, nearly all of such misclassified pixels were incorrectly classified as 
mixed stroma.  This result likely speaks more to the heterogeneity of stroma in general 
than to any serious problems with the classification itself.   
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3.6 Conclusions and Further Directions 
These results indicate that such a 6-class, supervised GML classification model can 
be used to successfully segment spectroscopic images of unstained sections of prostate 
tissue into useful histologic classes based on their spectral properties with respect to 
spectral class information from a database of previously imaged tissue from a number of 
patients.  Histological class information obtained from such images is useful for image 
display, however standard staining procedures are far cheaper and provide similar 
information.  FT-IR spectroscopic imaging data analyzed in this fashion can provide 
histological image information from unstained specimens.  Standard staining techniques 
can interfere with other analytical techniques, such as immunohistochemistry and in situ 
hybridization, as well as, nucleic acid recovery from laser capture microdissected 
material[142]. 
The histological class information obtained could also be used to study 
morphological relationships, such as epithelial/stromal density ratios in various different 
states of normal prostate tissue, nodular hyperplasia (BPH), and varying grades of 
prostatic adenocarcinoma[143, 144].  The supervised classification methods for providing 
histological class information from IR spectroscopic imaging data developed in the above 
sections are well-suited for automation, providing a means for rapid evaluation necessary 
for high throughput analyses.  
Furthermore, such histological classifications can be used as a tool for downstream 
analysis of spectral information from epithelial tissue in an effort to further study the 
infrared spectroscopic properties of benign prostate epithelial tissue and prostatic 
adenocarcinoma in many patients.  If reliable spectral indicators of disease presence and 
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progression can be found, then FTIR microspectroscopic imaging techniques can be used 
as an objective tool to aid in the detection and diagnosis of prostatic adenocarcinoma.  
The next section continues with some preliminary experiments using a third tissue array, 
P-80, designed to investigate some of these issues. 
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Chapter Four - Infrared Spectroscopic Histopathology of Prostate 
4.1 Classification strategy 
  Array P-80 is the most logical choice as a starting point for the analysis of 
spectral features of populations of benign and malignant prostate epithelial tissue.  Array 
P-80 was constructed from formalin-fixed, paraffin-embedded tissue blocks cut from 
radical prostatectomy specimens from population of 80 patients with confirmed prostatic 
adenocarcinoma.  The array was constructed with 2 cores from each patient, one from a 
region of representative adenocarcinoma, and one from a region with only normal benign 
epithelium.   The intention of the array design was to provide a large patient population 
and relatively even sampling of benign and malignant tissue for every patient.   
 The first step of the analysis will apply the histology classification developed in 
section 3, using the class statistics from the P-16-Array training populations to train the 
classifier.  The histology classification results will be used along with the pathologist’s 
interpretation of the matching H&E-stained section to designate separate ROIs for benign 
and malignant epithelium for each patient.  Mean spectra will be used to develop a large 
set of candidate spectral metrics for distinguishing between benign epithelium and 
adenocarcinoma.  Spectral metrics that show a statistically significant difference between 
the benign and adenocarcinoma populations will then be used in attempts to self-classify 
Array-P-80 and cross-validate by classifying other arrays with training data from Array-
P-80.  
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4.2 Array P-80 H&E Stained Section Pathology Analysis 
 The H&E stained, matching section of Array P-80 was carefully reviewed with a 
pathologist and each spot was evaluated for several histopathological parameters.  Before 
the review process, the visible optical image of each spot was printed on a separate sheet 
of paper and used to record the pathologist’s comments during the review process.  Each 
spot was assessed initially for tissue preservation and preparation.  Spots that contained 
significant preparation artifact or no epithelium were removed from analysis.  The 
pathologist carefully characterized the remaining spots and detailed records were kept for 
subsequent ROI creation and analysis.   The pathological status of epithelial tissue in 
each spot was considered individually and any epithelial tissue for which the pathological 
or preparation status was at all questionable was marked on the optical images so that it 
would not be considered in later analyses.   
All regions of confirmed prostatic adenocarcinoma were individually assigned a 
Gleason Grade of 1-5 indicating the predominant Gleason pattern seen in the spot.  Once 
the pathology analysis was complete, the results were tabulated and it was found that a 
total 38 patients contained usable benign epithelial tissue 51 patients contained usable 
regions of prostatic adenocarcinoma.  A total of 25 patients from array P-80 contained 
regions of both benign epithelium and confirmed prostatic carcinoma.  Without the 
corresponding benign tissue from the same patient as a control, any analysis of spectral 
features of adenocarcinoma tissue would be questionable.  For this reason, the full-
spectrum spectroscopic imaging datasets for the tissue array spots for these 25 patients 
were mosaicked into a single spectroscopic image for faster processing during 
downstream analyses.   
4.3 Array P-80 Histology Classification Results 
 The 18 histology metrics used in sections 3.5.5 and 3.6.1 were calculated for the 
new 25 patient image of array P-80 from the baseline-corrected full spectrum image data.  
The same histology classification performed in section 3.6.1 as cross-array validation, 
was applied instead to the 25-patient, 18-metric image of array P-80.  The 6 histologic 
class ROIs from array P-16 listed in table 3.4 were used as class training data for the 
GML classification of the 18-metric image.  The histology classification results for this 
25-patient image are displayed in Figure 4.1.  Figure 4.2 contains the corresponding 
optical images from the matching H&E stained section.   
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Figure 4.1- Array P-80 histology classification results 
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Figure 4.2 - Optical images of H&E stained section of Array P-80 
4.3.1 Spatial Filtering of Histology Classification Results 
The collected datasets have an effective pixel size of 6.25 µm x 6.25 µm.  The 
spectral data are collected over the wavelength range from 4000-720 cm-1, or 2.5-13.8 
µm.  A given pixel will therefore contain some spectral information from tissue locations 
represented in the image data by neighboring pixels.  Since most cells also have a size 
within or near the spectral wavelength range of radiation, some misclassification can be 
attributed to spectral bleeding from neighboring pixels that contain a different class of 
tissue.  As expected, this phenomenon is most prevalent along borders between different 
histologic classes.  Additionally, though the histological GML classification performs 
quite accurately, it is after all, a model and like all models has an inherent error rate.  
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While many types of spatial filtering techniques exist for digital image processing, the 
nature of the classification results suggest a particular method is most applicable for 
removing randomly distributed misclassified pixels.  Spectroscopic image data and 
spectral metric data both span continuous ranges of data values within a single image 
plane.   Most commonly applied spatial image filtering techniques work well with such 
data and involve some type of spatially-dependent averaging of pixel values within a 
defined local neighborhood of pixels. 
The GML classifier assigns each pixel in the image scene to one of 6 discrete 
classes.  Each class is represented in the image results data by a unique integer values.  In 
such a case, the data values associated with each pixel do not form any sort of continuous 
scale, thus any spatial filtering techniques that rely on averaging would produce 
meaningless results.   Several useful spatial filtering techniques have been developed for 
image classification results.  Some complex methods utilize the conditional probability 
statistics developed during the application of the GML classification algorithm to analyze 
individual pixels with respect to a defined local neighborhood of pixels.[62]    
 Two more simple operations, which also produce satisfactory spatial filtering 
results, are the sieve operation and majority analysis.  A sieve operation considers the 
neighborhood of pixels around a center pixel of class X, and applies a group minimum 
threshold.  If the number of pixels in the neighborhood classified as X is less than the 
group minimum, then the pixel is relabeled as unclassified.  The process is repeated for 
every pixel in the image.  An alternative spatial filtering technique that can be applied to 
improve the appearance of image classification results is a majority analysis.  This 
technique also considers a kernel, or set of neighboring pixels, which is rastered across 
the image pixel-by-pixel.  As the kernel moves, the center pixel is changed to the class 
that occupies the majority of the kernel positions that do not contain unclassified pixels.  
The weight of the center pixel can be changed in integer increments to alter the amount of 
filtering applied.  This technique provides effective filtering of randomly misclassified 
pixels and changes them to the class that dominates the neighborhood.  For this reason, 
majority-filtered images appear smoother than sieve-filtered results, which contain more 
unclassified pixels.   Figure 4.2 contains results of these two different filtering strategies 
on a small example region of a classified prostate histology image representing a typical 
border between epithelium and mixed stroma.   
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Figure 4.3 - Spatial filtering techniques for classified image results 
The majority analysis produces results that are extremely smooth and preferable for 
general classification image display, however, it is important to point out that the 
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majority analysis changes the class designation of pixels based solely on spatial 
information without any spectral information whatsoever.  At this stage in the data 
analysis, the sieve method is much more appropriate precisely because it is subtractive. 
Since the histology classification results will be used to construct epithelial ROIs for 
downstream spectroscopic analyses, it is important that such populations be as spectrally 
pure as possible.   
 The histology classification result image displayed in figure 4.1 was spatially 
filtered using a sieve operation implemented in ENVI using a neighborhood of eight 
pixels, and a group minimum threshold of five.  The results were qualitatively compared 
with the matching H&E section and found to provide satisfactory removal of randomly 
misclassified pixels, while also removing questionable pixels near class boundaries.   
Figure 4.3 contains images of the raw histology classification and post-sieve operation 
classification image for patient 2 from array P-80.  
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Figure 4.4 - Sieve operation spatial filtering of histology classfication results for patient 2 from array P-80 
4.4 Construction of a Supervised Classification Model for Prostate Pathology 
4.4.1 Creation of pathology ground truth ROIs 
 The sieved histology classification results produced in section 4.3 were used as the 
starting point for the designation of pathology ground truth ROIs for array P-80.  First, 
the sieved histology classification result for a given spot was compared with the 
annotated optical image of the matching H&E stained section.  The epithelial 
classification result pixels that corresponded to epithelial tissue selected for use in the 
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marked optical H&E stained imaged were grouped into separate ROIs for benign 
epithelium and prostatic adenocarcinoma for each patient for a total of 50 ROIs.  An 
image of the pathology ground truth ROIs and the corresponding number of pixels in 
each ROI is shown in Figure 4.4. 
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Figure 4.5 - Array P-80 pathology ground truth ROIs 
4.4.2 Pathology Spectral Data Reduction 
The mean infrared absorbance spectrum for each ROI was created and normalized 
to Amide II protein backbone absorbance at 1544 cm-1.  These mean spectra were 
compared and spectral features, frequencies, and band ratios could be identified for 
distinguishing benign epithelial tissue from prostatic adenocarcinoma.  A set of 54 
candidate metrics was developed involving absorbance band ratios and peak centers of 
gravity for features across the entire spectral region.  A listing of the parameters for each 
of the 54 candidate spectral metrics appears below in table 4.1. 
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Table 4.1 - Pathology spectral metric parameters 
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4.4.3 Histogram analysis of Spectral Metric Data 
Initial metric evaluation was conducted plotting histograms of different pathology 
ground truth ROIs for individual metrics.  Histograms analyzed on a patient-to-patient 
basis revealed that for many metrics, a similar directional shift in the means of frequency 
distributions between benign and adenocarcinoma populations was present.  For many of 
these metrics, while the direction of the shift was consistent from patient-to-patient, the 
absolute values of the respective distributions varied quite significantly among patients.  
This situation is depicted schematically in figure 4.5.  
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Figure 4.6 - Patient-to-patient metric variation 
 It was clear that many of these metrics were providing information regarding real 
spectral differences between benign and cancerous prostate tissue, however, the 
significant patient-to-patient variation rendered these metrics ineffective for use in 
parametric classification attempts.   
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4.4.4 Mean-centering of epithelial metric data. 
 The data were mean-centered in order to make use of the spectroscopic information 
contained in the metrics affected by significant patient-to-patient variation and to 
simplify the process of metric evaluation.  The mean metric spectrum for each patient’s 
benign ground truth ROI was calculated by averaging the individual metric-spectra 
within each ROI.  The discrete 54-metric spectrum of each individual epithelial pixel was 
divided by the mean benign metric spectrum from the corresponding patient.  This 
calculation  has the effect of normalizing the benign population distributions for all 
patients individually for each metric.  Thus, all patient-patient variation among benign 
metric distributions is effectively collapsed such that recalculation of the benign 54-
metric spectrum for any patient would yield a value of one at every metric. 
4.4.5 Metric Statistical Analysis 
A major advantage of mean-centering the metric data is that it simplifies the task of 
identifying which metrics provide statistically significant discrimination between benign 
and adenocarcinoma patient populations.  The mean 54-metric spectrum for each 
patient’s adenocarcinoma ground truth ROI population was recalculated from the benign 
mean-centered metric data.   A one population t-test was applied to each of 54 sets of 25 
patient-mean metric values to determine if the 25 patient population was significantly 
different from the constant 1.0  at the 0.05 level.  The results of the t-test for each metric 
and the associated p-values are listed in table 4.2. 
 Significantly 
different from 1.0?p-valuet-valueVarianceMeanMetric #
NO0.5010.6840.0031.00738
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NO0.907-0.1190.0020.99943
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-3.092
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Table 4.2 - Results of t-test on mean adenocarcinoma metric values from population of 25 patients on array 
P-80 for 54 candidate pathology metrics 
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The t-test results indicate that 20 metrics from the candidate set of 54 pathology 
metrics show statistically significant deviation between their respective populations of 
adenocarcinoma and patient-matched benign epithelial pixels.    
4.4.6 GML Pathology Classification of Array P-80 
 The set of 20 pathology metrics identified in section 4.2.8 for discriminating 
between benign and malignant prostate tissue were used as data for GML classification of 
all epithelial pixels from P-80 ground truth epithelial ROIs.  The benign ground truth ROI 
sets for all 25 patients were merged into one large benign training ROI comprised of 
19,492 total pixels.  Likewise, the adenocarcinoma ground truth ROI sets for all 25 
patients were merged into one large adenocarcinoma training ROI comprised of 42,239 
total pixels.   A supervised 2-class (benign epithelium & adenocarcinoma) classification 
was implemented in ENVI using the 20 metrics identified in section 4.2.8. 
The classification image results for all 25 patients appear below in Figure 4.6. 
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Figure 4.7 - Array P-80 pathology classification results 
 The ground truth training ROIs were used to construct an error matrix to evaluate 
the classification results on a whole-array basis.  The error matrix appears below in 
Figure 4.3.  
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Table 4.3 - Error matrix for 20-metric pathology GML classification of 
epithelial tissue on array P-80 
These classification results give a sense that in general, the classifier is performing  
adequately for distinguishing benign epithelium from regions of adenocarcinoma.  While 
very little misclassification of ground truth benign pixels is seen, there are a handful of 
adenocarcinoma spots in Figure 4.8 which seem to be classified with less certainty than 
the remainder of the patients.    
4.5 Individual Patient Evaluation of P-80 Pathology Classification 
The 20-metric pathology classification results were analyzed next on an individual 
patient basis.  For each of the fifty pathology ground truth ROIs (25 benign + 25 
adenocarcinoma), the percentage of ROI pixels classified as adenocarcinoma for each 
ROI was plotted as a bar chart in Figure 4.7 below.   
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Figure 4.8 - Individual patient analysis of 20-metric GML pathology classification 
The data reveals that the pixels from the benign ROIs of all 25 patients were 
classified with an accuracy > 80%.  Imposing a minimum threshold for adenocarcinoma 
classification of 20% on the data in figure 4.7 provides 100% discrimination between foci 
benign and malignant epithelial tissue across the entire population of 25 patients.   
4.6 Cross-Array Validation 
Again it must be noted that such self-evaluation of training data ROIs represents the 
best possible scenario for producing accurate supervised results.  To examine the cross-
array performance of the pathology classification model, training data from array p-80 
was used to classify mean-centered 20-metric data from other arrays. 
Upon the pathologist’s review of the H&E stained section, arrays P-16 and P-40 
were each found to contain 5 patients with usuable regions of both benign epithelium.  
Initial cross-array classification attempts did not yield consistent results.  While some 
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individual patients yielded results similar to those seen with Array P-80, the limited 
population sizes of five patients on each array made it impossible to draw any substantive 
conclusions regarding the cross-array performance of the developed pathology 
classification model. 
4.7  Conclusions and Further Directions 
These results indicate that spectral features from FTIR spectroscopic imaging data 
can be used to differentiate between regions of healthly benign prostate epithelial tissue 
and regions harboring prostatic adenocarcinoma.  The results presented in this section 
represent an initial attempt to probe the infrared spectroscopic characteristics of prostate 
histopathology and serve to highlight the promise that such vibrational spectroscopic 
imaging techniques hold for the objective analysis of sectioned tissue.   
Such methods provide simple, readily interpretable image-based results that convey 
histological and pathological information provided by referencing spectral database 
information.  Some of the most useful of these preliminary results are those from section 
4.8 from the t-test analyses of individual metrics.   
The t-test results displayed in table 4.2 show the 20 metrics for which the patient 
populations of patient-mean adenocarcinoma metric values differed significantly from 
corresponding benign metric values.  Close examination of the spectral parameters of 
each of these 20 metrics listed in table 4.1 reveals that most successful metrics involve 
spectral information from a handful of spectral regions corresponding to specific 
vibrational modes.  Several metrics involve spectral information from the spectral region 
between 1200-1000 cm-1, a region with prominent absorbances due to vibrational modes 
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of glycogen, as well as symmetric stretching of phosphodiester (PO2-) groups of nucleic 
acids.  The region between 1300-1200  cm-1 also contributed to several metrics; this 
region contains spectral absorbances due to protein Amide III modes and antisymmetric 
stretching modes of nucleic acid PO2- groups.    Finally, many metrics involved features 
from the spectral region between 1590-1500 cm-1, a region whose main absorbance is the 
Amide II mode of proteins arising from N-H bending modes coupled to C-N stretching 
on the protein backbone. 
Future spectroscopic imaging of prostate tissue at higher spectral resolutions will 
allow more information to be extracted from these spectral regions.  Alternative 
classification methods, such as spectral-angle mapping and hierarchical cluster analysis 
more readily make use of continuous spectral information, and can be employed using 
data from these isolated regions of the spectrum.  If performed on substantially larger 
patient populations, it is likely that such approaches will lead to more specific 
information regarding, spectrally similar subgroups of related cancers and correlations 
with histologic grade and/or disease progression  
Clearly, studies conducted with larger tissue microarrays and patient populations 
will advance our understanding of the spectroscopic properties of prostate pathology.  
The technology utilized to collect vibrational spectroscopic imaging data is advancing at 
a rapid pace.  Faster collection times, better SNRs, and higher data collection at higher 
spatial and spectral resolutions will all add to the power of this technique in the future.   
Among the most promising future analytical approaches will be to create techniques 
to register spectroscopic image data with results from other analytical techniques, such as 
immunohistochemical staining and in-situ hybridization conducted after IR data 
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collection, or performed on serial tissue array section.   Such combinatorial approaches 
should enable calibrations to be constructed that could tentatively predict staining 
patterns for multiple panels of antibodies or other probes via spectral pattern recognition 
from spectroscopic image data of unstained tissue.   
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